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Single Nucleotide Polymorphisms (SNPs) are common genetic variations 
associated to specific phenotypes. SNPs have high relevance in different 
biomedical areas including both preventive/personalized medicine and non-
clinical contexts, such food traceability. However, current techniques for SNP 
genotyping are expensive, require specialized laboratories and costly 
instrumentations, and are time consuming. In this framework, the development 
of rapid, point-of-care (POC) SNP diagnostic technologies would be of great 
interest, opening new possibilities for early, on-site screenings in multiple fields. 
In this PhD thesis, starting from state-of-art approaches, a rapid and portable 
diagnostic strategy based on Loop Mediated Isothermal Amplification (LAMP) 
has been developed for SNPs genotyping. In particular, the developed strategy 
was applied and validated, in a naked-eye colorimetric approach, for food 
varietal discrimination (i.e. durum wheat variety) in a model case of industrial 
relevance. Moreover, the POC technology was targeted to different salivary 
biomarkers, to address nutrigenetics and pharmacogenetics issues. Notably, the 
possibility to rapidly diagnose the genetic predisposition to lactose intolerance 
or the impairment of folic acid metabolism was proven. Furthermore, the 
developed POC-compatible protocols can work with portable, battery-powered 
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1.1 In vitro diagnostics and Point-of-Care testing 
In Vitro Diagnostics (IVD) includes instruments, techniques and reagents that allow to identify 
and/or monitor a specific target or a condition. 
Over the years, the concept of In-Vitro Diagnostics has evolved, requiring new tools and 
strategies to satisfy the current need to provide fast, on-site and cost-effective diagnostic 
responses, ensuring at the same time high performance in terms of sensitivity, specificity and 
reliability. 
In clinical practice, the shift from a curative to a preventive health system has led to an 
increasing demand for early diagnosis and personalized medicine. Moreover, among the 
others, the development of new genetic tests is strengthening the concept of predictive 
medicine, that allows to evaluate predisposition and susceptibility of the patient to a certain 
physiological or pathological condition, facilitating targeted treatments. 
New diagnostics tools are advantageous also in other fields, such as in quality control, in 
industrial and agri-food sectors. In fact, nowadays, government regulations and people 
consciousness about food quality standards and environmental issues, are calling for 
increasingly stringent quality controls, with frequent and massive checks along the entire 
production chain.  
Overall, this situation has resulted in a huge expansion of In Vitro Diagnostics (IVD) market 
with a constantly growing future trend 1. Indeed, considerable efforts are being doing by 
scientists and researchers to develop new pioneering technologies for diagnostics, focusing 
in particular on on-site and Point-of-Care (POC) diagnostics, that allows testing at the point of 
need, in centralized laboratories as in decentralized settings, such as pharmacy, the 
physician's office or even at home, raising patient compliance and promoting rapid-testing, 
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or directly at food processing step in industrial contexts. Traditional diagnostics requires 
multiple and time-consuming processes, involving expensive instrumentation and qualified 
personnel. On the contrary, on-field diagnostics is fast, and it can be performed in portable 
devices, providing reliable and sensitive responses. Furthermore, POC tests speed up the 
turnaround time of the analysis and as a consequence, the decision time 2. This is a key point 
not only in medicine, but also for example for food supply chain because the perishable nature 
of food and the food market related economy raise the need for rapid tests that allow quality 
control checks and a prompt non-compliant batch withdrawals. 
Among all the emerging POC tests, cellphone (CP)-based technologies provide measurement 
of biological markers or environmental contaminants with a portable smartphone-like device 
3, 4, 5. Two examples of commercially available and commonly used POC tests are pregnancy 
test and glucose meters 6, 7. These systems provide an incredible advantage to the home-
based monitoring of a therapy enabling a clear and unique interpretation of results and the 
possibility to transmit clinical data.  
Among all the wide range of analysis that can be performed through In Vitro Diagnostics, 
there are genetic tests. Genetic tests are almost exclusively performed in specialized 
laboratories, and they require a long turnaround time and high costs. For this reason, the 
availability of a genetic pre-screening system in decentralized settings would be very 
innovative.  
Indeed, POC for Nucleic Acid Testing (NAT) are emerging among POC tests. POC-NATs allow 
to identify the DNA or RNA of a specific target. POC-NATs are applied in several fields enabling, 
for example, the detection of bacterial and, viral infections, allowing an easy management of 
a therapy or even, in industrial field, facilitating the monitoring of potential adulteration of 
end products 8. Two examples of POC-NAT complete technologies that present the possibility 
to automate the entire process are the GeneXpert and the IQuum LIAT systems that have 
been studied for the diagnosis of tuberculous pericarditis and HIV infection, respectively 9, 10. 
At the basis of a POC-NAT test usually there is a nucleic acid amplification step. The gold-
standard amplification technique is the PCR (Polymerase Chain Reaction). However, since PCR 
requires thermal cycles, it is commonly performed with a specific instrument, the 
thermalcycler. Moreover, PCR is susceptible to inhibitors, hence it requires an elaborate 
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extractive phase to obtain an extremely purified nucleic acid target. For these reasons, the 
development of POC-NAT technologies based on PCR requires the design of a complex bench 
top technology able to perform DNA extraction, DNA amplification and detection.  
An alternative to the use of PCR-based methods is the employment of isothermal 
amplification reactions, where the amplification of the nucleic acid target occurs at a single 
reaction temperature. In this way, such amplification reactions can be performed in a simple 
heater device reducing costs and complexity. For all these features, the use of an isothermal 
amplification method appears the strategic choice for the development of a POC platform. 
 
1.2 Isothermal amplification techniques 
Polymerase chain reaction (PCR) is the gold standard strategy for nucleic acid amplification in 
molecular biology 11. This technique operates the amplification through thermal cycles and 
consists of three stages: denaturation, annealing and extension. The first step, typically at 94-
95 °C, is the heat denaturation step that determines the opening of the double strand of the 
DNA target molecule and prepares the target for the subsequent stages; in the second step 
the primer anneals to the complementary region on the single-strand target; during the third 
step, the primer is elongated and a new molecule of DNA is produced. All these stages are 
repeated one after the other leading to an exponential amplification that permits to amplify 
up to 106 copies of the starting template.  
Since the thermal cycles can be operated only through an expensive instrument, the thermal-
cycler, the use of the PCR is not convenient for a POC test. On the contrary, isothermal 
amplifications represent the most suitable techniques for portable applications. These 
strategies permit to exponentially amplify nucleic acids at one unique temperature bypassing 
more complex procedures. Several isothermal amplification methods for both RNA and DNA 
templates have been proposed in literature (Figure 1) 12. 
Nucleic Acid Sequence-Based Amplification (NASBA) and Transcription Mediated 
Amplification (TMA) are both examples of techniques for isothermal amplification of RNA. 
These approaches exploit the function of a Reverse Transcriptase enzyme which synthetize a 
double stranded DNA (cDNA) starting from the target RNA. The cDNA produced represents 
then the starting point for the later amplification of the RNA product by a DNA dependent-
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RNA polymerase. The starting primer includes both a sequence complementary to the target 
RNA and a t7 promotor sequence. Together the activity of an RNase and two primers generate 
a double stranded cDNA containing the site for initiating RNA synthesis 13, 14, 15. 
Another method, named Signal-Mediated Amplification of RNA Technology (SMART), works 
with the generation of a three ways junction structure thanks to the special design of primers. 
The specific design of the probe forces the direction of the DNA synthesis towards the strand, 
which is perpendicular to the target sequence. The newly formed double stranded DNA which 
contains a t7 promotor sequence enables the exponential RNA synthesis 16. 
Furthermore, many others isothermal amplification methods for DNA amplification are 
reported in literature, such as Strand Displacement Amplification (SDA), Helicase-dependent 
amplification (HDA), Rolling circle amplification (RCA) and Recombinase polymerase 
amplification (RPA). For example, SDA method is based on the use of a restriction enzyme and 
a 5'-3' exonuclease deficient DNA polymerase with strand displacement activity. In the first 
proposal of the strategy two primers containing the binding site for a restriction enzyme were 
used. The 3' end of the template is then extended using the attached primer as template. 
Nucleotides with a thiophosphate modification are used for DNA synthesis, thus the 
restriction enzyme is able to cut only the unprotected strand of the DNA. The enzyme nicks 
the unmodified strand, the DNA polymerase, lacking 5'-3'exonuclease activity, repairs the gap 
and displaces the downstream strand. Cleavage, extension and displacement are repeated 
several time triggering isothermal exponential amplification. In the first proposal of SDA 
method the initial steps require both a denaturation step to obtain a single strand nucleic acid 
and a pre-cleavage of the DNA sample operated by a restriction enzyme in order to generate 
a DNA fragment with determined 5' and 3' ends 17. This step was overcome by the addition of 
two displacement primers that generate a fragment with two restriction sites at both ends. 
This optimization permits to obtain a template immediately available for following stages of 
the amplification 18. 
Rolling cycling amplification (RCA) is another strategy that exploits the ability of DNA 
polymerase to utilize circular templates. This method is based on the use of a special probe, 
which, after its hybridization to the target sequence, causes the closeness of the ends, 
circularizing the target nucleic acid. Subsequently a DNA ligase binds both ends and completes 
the circularization. Upon the circularization of the template, a second primer hybridizes the 
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sequence. Then, it is extended by a DNA polymerase, producing a long repeating single 
stranded sequence 19. 
However, all the methods described above require a starting heat denaturation step, while 
later stages are performed at one unique temperature, thanks to the strand displacement 
activity of the polymerase or, in case of RCA, to the generation of a linear sequence product. 
Another approach described in literature is Helicase-dependent amplification (HDA). In this 
method, double stranded DNA is uncoiled by a DNA helicase. Then two primers anneal to the 
opened double stranded and a DNA polymerase extends the primers. Two molecules of 
double stranded DNA that are new substrates for DNA helicase are generated, fueling the 
cycle. This technique provide 106 fold amplification in 3 hours and the entire process is 
performed at one temperature not requiring a pre-heating step 20. 
Recombinase Polymerase Amplification (RPA) is a strategy that exploit the activity of a 
Recombinase. The complex Recombinase-primer scans the target sequence and binds to the 
site complementary to the primer. The primer is extended by a DNA polymerase and the new 
generated DNA strands acts as starting point for the exponential amplification. Also in this 
case the use of a polymerase with strand displacement activity is required and the entire 
reaction is performed at one unique temperature 21. 
Nowadays, among all the isothermal amplification techniques, Loop-mediated isothermal 
amplification (LAMP) is emerging and attracting great interest due to its rapidity, its high 









1.3 Loop-mediated isothermal amplification (LAMP) 
In 2000, Notomi and co-workers proposed a new isothermal amplification strategy, the Loop-
mediated isothermal amplification (LAMP) method. This approach revealed to be efficient 
and fast presenting a lot of advantages if compared to others strategies 22. With LAMP 
technique DNA is amplified 109-1010 times in 15-60 minutes. 
The amplification proceeds at a constant temperature exploiting a DNA polymerase with a 
high strand-displacement activity and four specially designed primers, complementary to six 
distinct regions on the target sequence. In PCR-based technique, exponential amplification is 
operated by thermal cycles, while in LAMP it is obtained thanks to the strand displacement 
activity of DNA polymerase together with the formation of single stranded loop, in the stem-
loop structures. A stem-loop structure or hairpin is a secondary structure that can occur in 
single-stranded DNA or RNA. This kind of structure is formed when two regions of the same 
strand are one identical and one complementary to another region of the same strand. The 
annealing of these complementary regions enable the formation of a double strand portion 
(stem) and a single strand structure (loop). To form a stem-loop structure, the length and the 
composition of the strand are fundamental. Moreover, this structure is formed if it has 
enough thermodynamic stability. In particular, between the two complementary regions, a 
sufficient number of nucleotides is required to obtain the folding and generate a stable loop 
structure. In addition, also the composition of the complementary portions influences the 
stability, affecting the thermodynamic balance between the linear and the stem-loop 
structure.  
In general, four primers are involved: forward and backward inner primers (FIP and BIP), and 
forward and backward outer primers (F3 and B3), designed on six regions of the target 
sequence: F3c, F2c e Fc1 at 3’ end, and B1, B2 e B3 at 5’ end.  
Forward Inner Primer (FIP) consists of the F2 region (at the 3' end) that is complementary to 
the F2c region, and the same sequence as the F1c region at the 5' end. Backward Inner Primer 
(BIP) is designed in the same way on the complementary strand. 
Forward Outer Primer consists of the F3 region that is complementary to the F3c region. 





Figure 2. Schematic representation of four primers for LAMP reaction and their corresponding six 
binding regions on the target sequence 23. 
 
At the temperature around 60-65°C the double stranded DNA is in the condition of dynamic 
equilibrium. Indeed, one of the LAMP primers can anneal to its complimentary sequence on 
the target gene, without requiring an initial heath denaturation step at higher temperature. 
The reaction starts with the hybridization of F2 portion of FIP with F2c region in the target 








DNA polymerase extends the 3’ end of FIP synthesizing a DNA strand complementary to the 
template (Figure 4); meantime, the outer primer F3 binds F3c region of the target sequence 
(Figure 5).  
 
 




Figure 5. Step 3 of LAMP reaction 23. 
 
F3c region is located upstream to F2c, therefore F3 extension by DNA polymerase with strand 
displacement activity causes the release of the newly synthetize product (Figure 6 and 7). 
 






Figure 7. Step 5 of LAMP reaction 23. 
 
As the first product is displaced, F1c portion of FIP at the 5’end of the newly formed product 
can self-hybridizes to F1 region, creating a stem-loop structure. This newly generated strand 
works as template for the BIP-mediated synthesis and subsequent B3-primed strand 
displacement DNA synthesis (Figure 8). 
 
 
Figure 8. Step 6 of LAMP reaction 23. 
 
BIP through its B2 portion binds to B2c of the strand and, starting from the 3' end of the BIP, 
the synthesis of complementary DNA takes place. (Figure 8). Through this process, the DNA is 
reverted into a linear strand. 
Subsequently B3 anneals with B3c region, DNA polymerase synthetizes a new strand by the 
extension of B3 and displaces the product (Figure 8 and 9). The single strand product rapidly 
forms a structure with stem-loops at each end, named dumb-bell structure, thanks to the self-
hybridization of F1 with F1c and B1 with B1c (Figure 10). 
 
 





Figure 10. Step 8 of LAMP reaction 23. 
 
The stem-loop structure contains a single stranded DNA portion (the loop) and a double 
stranded one (the stem). This structure contains multiple sites for primers annealing and 
consequently leads to the exponential amplification stage. Starting from this structure, the 
amplification continues exponentially. The self-priming at the 3’ end of F1 portion leads to 
the extension of the strand. Simultaneously, FIP anneals to the F2c portion of the stem-loop 
construct triggering the synthesis of a new strand (Figure 11a and 11b). Then, the strand 
displacement activity of the DNA polymerase causes the release of the strand synthesized by 
the extension of FIP (Figure 11d). This strand generates a dumb-bell structure with single 
strands loops at both ends (Figure 11d). The newly generated dumb-bell represents the 
complementary configuration of the starting structure. Then, B1 portion at the 3’ end of the 
new product behaves as a primer triggering DNA synthesis and BIP anneals to the B2c portion 
of the stem-loop structures (Figure 11d and 11e). Rapidly, this strand is displaced and it forms 
a stem-loop structures by the annealing between the newly formed portions, B1 and B1c, and 
by the hybridization of F1 with F1c portions (Figure 11a). In this way, the amplification restarts 
23. 
Finally, in the elongation and recycling steps, FIP and BIP continue to hybridize to the template 
and the DNA polymerase continues to displace newly synthetized strands. The ending 
products are multiple stem-loop structures, called cauliflower-like structures, with alternately 
inverted duplicates of the starting template (Figure 11f). The effect of the amplification is the 





Figure 11. Cycling amplification steps 23. 
The particular design of FIP and BIP primers has a pivotal role in the reaction mechanism. The 
elongation of inner primers permit the self-hybridization of the product and the formation of 
the dumb-bell structure.  
For initial steps of LAMP reaction, all the four primers are used, while later phases requires 
only the action of FIP and BIP. For this reason, the needed amount of F3 and B3 primers inside 
the reaction mix is lower in comparison with inner primers concentration. 
In the first proposal of the LAMP technique, the first step required was the heat denaturation 
of the template while the subsequently steps are under isothermal condition. Afterwards, it 
was observed that at the temperature between 60 and 65 °C and in presence of high 
concentration of betaine the double-stranded and the single stranded DNA configurations are 
in a thermodynamic balance 24. This particular condition favors the annealing of inner primers 
and permits to avoid the initial heat denaturation step, allowing the entire process to be 
performed under isothermal condition.  
18 
 
In 2002 Nagamine et al. proposed a pivotal improvement of the LAMP, introducing the Loop 
primers, that provided a significant acceleration of the reaction time 25.  
The Loop primers (either Loop primer B or Loop primer F), contain sequences complementary 
to the single stranded loop region, and they are designed between the B1c and B2c regions 




Figure 12. Schematic representation of the six primers involved in LAMP amplification, including loop 
primers introduced by Nagamine, and their corresponding eight binding regions on the target 
sequence. 
 
Loop primers anneal to a portion of the dumb-bell structure that is not involved in the 
annealing with inner primers, providing an increased number of starting points for DNA 
synthesis for the LAMP method. (Figure 13). 
These primers act in the latest phases of the reaction: the elongation and recycling steps. 
Since loop primers hybridize to the “available” loop regions of the dumbbell, they act together 
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with FIP and BIP. In this way, all the single strands formed during the amplification can be 
used as starting point for DNA synthesis. 
Therefore, the main effect of the introduction of Loop primers is the increasing of the 
amplification rate and a significant lowering of the reaction time.  
 
Figure 13. Schematic representation of the loop primers binding sites on the dumb-bell structure (a) 
and an example of a LAMP product containing multiple sites for Loop primers annealing (b) 23. 
 
Detection of LAMP products can be achieved in Real-Time or through an end-point strategy. 
Real-Time detection is achieved using fluorescent DNA intercalating agents that are 
incorporated into the DNA structure 26. SYBR green I, for example, binds the dsDNA molecules, 
and the resulting fluorescent emission obtained is directly proportional to the amount of 
amplicons produced.  
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The standard end-point detection is the analysis of LAMP products carried out by gel 
electrophoresis. During the gel preparation an intercalating agent, such as ethidium bromide 
or its safe alternative dye, the SYBR Safe, is added. The result of gel electrophoresis, visible 
through the UV light irradiance, is called “smear” because LAMP products migrate differently 
due to their different length and to their complex structure 27.  
A second method is based on the visualization of a white turbidity in the reaction tube. This 
phenomenon derives from the precipitation of magnesium pyrophosphate formed by the 
interaction between pyrophosphate, which is formed during amplification, and magnesium 
ions, which are abundant in the reaction mix 28.  
This by-product is produced in proportion to the concentration of amplified products, which 
is in a greater amount after LAMP amplification. This observation has opened the perspective 
for the possibility of visualize LAMP products directly in the reaction tubes allowing a naked-
eye and instrument-free detection. Moreover, other substances able to improve the rapid 
visualization of the results can be added, for example fluorescent metal ion indicators, such 
as calcein, or colorimetric indicators such as Hydroxy naphthol blue (HNB) 29, 30. 
A recent strategy for end-point LAMP detection is based on the use of pH-sensitive dye 
enabling the detection of LAMP products through a color change 31, 32. During the DNA 
synthesis, a proton is released for every new phosphodiester bond formed (Figure 14). 
 
 
Figure 14. Formation of a phosphodiester bond during DNA synthesis. This biochemical reaction, 




Unlike PCR, in the LAMP amplification, the high concentration of long and complex 
amplification products causes a drop in the solution pH of more or less 2 units, starting from 
the standard solution pH around 8.5.  
This method can be used only for LAMP reactions. In fact, PCR leads to the formation of 
amplicons with the same length determined by the position of the primers. For this reason, 
there isn’t a sufficient proton’s release to achieve such a lowering of the pH. In LAMP, this pH 
change can be detected with an appropriate organic dye that has different colors for the acid 
form and the basic one, and that is able to give a visible solution color change in the reaction 
transition pH range.  
PH-sensitive dyes are low-cost, well-functioning and can lead to a clear naked-eye 
visualization of the result. Moreover, pre-addition of dye inside the reaction mix permits to 
avoid the opening of the reaction tube that can cause cross-contaminations caused by 
reaction amplicons, highly probable due to high sensitivity of the LAMP reaction. 
Among all these detection methods, the fluorescence-based detection is advantageous 
because it is fast. On the other hand, colorimetric detection methods make easier the 
interpretation of the results. 
In addition, LAMP has high tolerance to contaminants allowing the employment of simplified 
nucleic acid extraction protocols into a POC platform 33. All these features make LAMP a 
powerful technique ideal to develop a portable test. 
 
1.4 Single Nucleotide Polymorphisms (SNPs) 
In 2003, the whole human genome was sequenced by the Human Genome Project, which 
gave to the scientific community an huge heredity 34, 35, 36. This project paved the way for 
characterizing most of the genetic variations distributed through the whole genome. Among 
these variations, Single Nucleotide Polymorphisms (SNPs) were discovered with a frequency 
of 1 bases every 1000 in the human genome 37. This type of polymorphisms are defined as a 
substitution of a single nucleotide at a specific position in the genome, with a frequency of at 
least 1% in a random set of individuals in a population. SNPs can be located in non-coding 
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regions of the genome, without any impact on the phenotype of an individual, in coding 
regions or in a regulatory part of a gene, altering in these way the function of the encoded 
protein 38. Moreover, it is well established that genetic variations are associated to 
phenotypical features that can affect individual responses to nutrients or drugs. The presence 
of the polymorphic version of a protein can influence the protein function and, if such a 
protein is involved in a particular metabolic pathway, it can modulate the response to a 
certain substance, such as a supplement or a pharmacological treatment 39, 40, 41. Nowadays, 
since SNPs are strongly associated with well-known disease or pharmacological side effects, 
personalized medicine, based on the delineation of the individual and specific genetic profile 
of patients, is attracting attention.  
Moreover, SNPs are the most abundant genetic variation of all the genomes. Hence, they 
represent biological markers for identification of foods varieties 42, 43. In this framework, SNPs 
are exploited as markers for unequivocal authentication in food traceability field 44.  
For these reasons, SNP detection provides several advantages for a broad range of 
applications. Several PCR-based techniques for SNP genotyping have been developed and 
described in literature 45, 46. The simplest approach is the hybridization method that enables 
the allele specific discrimination with two single-stranded DNA molecules employed as 
probes. Only the perfect matched annealing is stable and provides a specific discrimination. 
The correct hybridization between the target DNA sample and the probe can be revealed by 
a fluorescence emission that is evidence of the detection of the correspondent allele type. A 
particular example are molecular beacon probes that are single-stranded oligonucleotides 
with a fluorophore and a quencher covalently bonded to the respective ends. In such a case 
when the probe is annealed to the target sequence the quencher is sufficiently separated to 
the dye in order to not inhibit the fluorescence emission 47, 48. Hybridization-based 
mechanisms are suitable for solid supports, such as microarray technology, enabling 
simultaneous detection of multiple markers. Another method for allele discrimination is 
based on primer extension, in fact, only in case of a perfect match between the target 
sequence and the primer, the synthesis proceeds highlighting the presence of the related 
allele type 49. Another method involves DNA ligase enzyme that due to its high specific activity 
can be used for discrimination. In this approach, two adjacent probes are linked together by 
the action of ligase enzyme only in case of a correct annealing 50. Finally, the invasive cleavage 
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approach relies on the simultaneous annealing of two probes overlapping for a single 
nucleotide creating a structure that is recognized by an endonuclease. The cleaved product is 
the result of the correct detection 51.  
Overall, the most accurate method for SNP genotyping is the genome sequencing that, albeit 
with a high cost, enable the reading of the entire target sequence 52. The first sequencing 
method was developed by Fred Sanger in 1997. After being developed in 1977, it was first 
commercialized by Applied Biosystems in 1986. The method relies on the use of chain-
terminating dideoxynucleotides 53.  
In the last years, next generation sequencing (NGS) or high throughput technologies have 
been developed, allowing to sequence many fragments in parallel generating a high number 
of data. Since the introduction of the methodology by Sanger, sequencing technologies has 
made great strides significant reducing costs. Moreover, NGS technology has influenced the 
production of dozens of prokaryotic and eukaryotic genome assemblies, including model and 
crop plants. However, NGS requires very expensive technologies and a big effort for data 
analysis. Indeed, the main limits that preclude SNP genotyping to routine diagnosis are the 
high costs and the laboriousness nature of these techniques that can be performed 
exclusively by skilled users in specialized laboratories. Indeed, easier and portable tools for 
SNP identification would further widen the possibility of taking advantage of informativity of 
genetic variations. 
 
1.5 SNPs detection with LAMP technique  
LAMP strategies for SNP detection are generally based on the modification of the design of 
primers. In order to distinguish both the wild-type and the polymorphic alleles, two versions 
of the same primer are employed. The most common approach described in literature, 
proposes to design inner primers in order they hybridize to the polymorphic or the wild-type 
base with the 5’ end of both FIP and BIP 54, 55 or with the second base at the 5’ end of FIP and 
BIP 56. Using the FIP complementary to the wild-type sequence, the dumbbell-like starting 
structure is formed and the DNA synthesis proceeds, while when the target gene is the mutant 





Figure 15. Schematic representation of the most commonly used LAMP-based SNP detection method 
23. 
 
Alternatively, the use of outer primers as allele-discriminating primers is proposed, placing 
the mutation at 3’ end of the F3 sequence 57 or employing one inner primer with the mutated 
base at 5’ end 58. For all these strategies, in presence of the wild-type nucleotide the reaction 
performed with wild-type primer proceeds, while in presence of the polymorphic one the 
synthesis performed with wild-type primer is inhibited. Another approach described in 
literature is Peptide Nucleic Acid-Locked Nucleic Acid (PNA-LNA) mediated LAMP method. 
PNA probe is complimentary to the wild-type sequence and forms a thermodynamic stable 
complex with the dumbbell structure preventing the annealing and the extension of the LNA 
primer 59. In this case, the amplification in presence of the wild-type sequence is blocked, 
while it occurs in presence of the mutate genome. Anyway, many of these approaches lead 
to a high background and a low discrimination efficiency due to the only partial inhibition of 
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Aim of the work 
The aim of this thesis work was the development of a competitive tool for SNP genotyping, 
fine-tuned to be integrated in a Point-of-Care platform. 
In particular, this approach expected to be simple, rapid and suitable for on-site and large-
scale screenings, with the purpose to propose an alternative solution to the complex and 
time-consuming traditional SNP-diagnostics. Moreover, the purpose was to develop a highly 
versatile test workflow, supported by a tailorable design and applicable, in this way, to a 
broad range of purposes.  
For example, in industrial settings SNPs can be exploited as markers to unequivocally track 
commodities along the production chain. In such cases, managing directly on-site a high 
number of samples can provide remarkable advantages in standardized controls.  
For these purposes, the objective of this thesis work was to propose a reliable tool able to 
meet the industrial requirements, introducing a minimally instrumented protocol with a 
rapid and simple procedure, to allow the rapid genotyping of a large number of samples and 
facilitate quality controls.  
In clinical field, SNPs are highly relevant also for nutrigenetics and pharmacogenetics. In 
particular, several SNPs have been associated to the genetic predisposition to food 
intolerances, while some others have been linked to the susceptibility to drug treatments. 
Therefore, the on-site identification of the patient genetic profile can be useful for the 
Specialist to recommend the appropriate diet or pharmacological treatment. In these 
contexts, the aim was to offer an easy-to-use assay, based on a minimal instrumentation 
requirement and basic user-skills, designed to be performed in non-specialized settings, as 
for example at the Doctor’s office or Pharmacy. Beside the test portability, the main goal of 
the thesis work was to propose a highly acceptable test, introducing a non-invasive sampling 











Model case for the optimization of PE-LAMP-Based assay  
 
2.1 Introduction 
Beside all the LAMP-based techniques for SNP genotyping covered above, a recent one 
proposed by Ding and collaborators in 2019 called probe-enhanced loop-mediated isothermal 
amplification (PE-LAMP) has revealed very effective.  
Loop primers (LPs) have a pivotal role in the Ding’s proposed strategy. In fact, in this strategy, 
LPs act as allele discriminating probes. To perform this role LPs are designed shorter in 
comparison with classic LAMP protocol and only one LP, forward or backward, is pre-added 
to each reaction mix. 
The principle for SNP genotyping is based on designing two versions of the same LP: one 
complementary to the wild-type allele, and the other one perfectly matched with the 
polymorphic site. In particular, for each sample two reaction are performed in parallel, 
differing only for the type of LP used. 
The core of the approach relies on triggering the specific annealing, while disfavoring the 
mismatched one. In this situation, a single mismatch located on a short primer significantly 
affects the thermodynamic stabilization of the bond between the probe and the template, 
impacting on the reaction efficiency. LPs act as accelerating primers, speeding up the onset 
of the amplification. Indeed, the reaction where the LP is perfectly hybridized will be properly 
enhanced, while the one with the mismatched annealing between the LP and the target 
sequence will be delayed. The discrimination between the two possible allele types is based 
on the time of onset of two concurrent reactions that depends on the stabilization or 









Figure 16. Schematic representation of SNP detection using PE-LAMP. In this strategy the SNP site on 
the target sequence corresponds to the LP binding site. The amplification proceeds forming a dumb-
bell structure with the polymorphic nucleotide located on the loop portion. In this case the LP for the 
detection of the mutant target is designed and it is employed for the amplification of both mutant 
and wild-type samples. Indeed, this LP primer will trigger the accelerated amplification of the 
reaction containing the mutant target. However, it will not be able to proper enhance the reaction 
containing the wild-type target. Therefore, the two resulting amplification curves will differ for 
amplification efficiency 1. 
 
Since this strategy resulted effective for SNP genotyping, in this thesis an in-depth 
optimization was performed.  
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2.2 Results and discussion 
In this thesis, starting from the state-of-art PE-LAMP approach 1, an optimized SNP genotyping 
strategy was developed, investigating one by one all the factors that influence the 
discrimination efficiency.  
The mechanism was studied starting from Ding’s outcomes and using the same model case: 
the polymorphism rs3741219. This particular genetic variation is located on Long Noncoding 
RNA H19 and in Chinese population is associated with the predisposition of insurgence of 
breast cancer 2. Although in Italian population the selected SNP is not associated with any 
particular phenotype, since it is present in the general population, it was use as model SNP 
for the here-presented thesis work. 
Human genomic DNA target for performing the assay was obtained from salivary samples. In 
fact, buccal epithelium cells are present in saliva. DNA was extracted from these cells with a 
simple protocol through a thermochemical lysis. 
In rs3741219, the wild type allele has the nucleotide T, while the mutant one presents the 
nucleotide C.  
As reported by Ding and collaborators, the method relies on the single SNP discrimination 
operated by loop primers (LPs). Accordingly to the principle of the strategy, two versions of 
the same LP were designed: LP-A, complementary to the wild type site, and LP-G, 
complementary to the polymorphic base. Two reactions were performed in parallel, one pre-
adding LP-A and the other one pre-adding LP-G, to ensure that the same target was analyzed 
with both probes. 
The different behaviors of the reactions, linked to the allele type present in the investigated 
sample, allowed the SNP genotyping. When the analyzed sample was a heterozygous type for 
the investigated SNP, then both amplifications were properly enhanced, otherwise, in case of 
a homozygous sample, the two reactions proceeded differently, in particular, the perfect 
matched reaction was significantly accelerated in comparison with the mismatched one. 
In order to replicate the published results, the best performing pairs of primers that resulted 
by Ding’s study were tested using human DNA of a volunteer resulted heterozygous for the 
investigated polymorphism. Amplification reactions were performed in Real-Time following 
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the fluorescent emission of SYBR green I dye, that bounds in a non-specific way the dsDNA, 
revealing the formation of LAMP products. The starting reaction conditions were identical to 
those applied by Ding et al. The employed LPs was composed by 11 nucleotides and the SNP 
site was located at the center of the probe. For an easier comprehension of the work, this 
couple of primers was named set 1. Although the DNA derived from a heterozygous 
individual, the reaction performed with LP-A resulted slightly delayed in comparison with the 
one performed with LP-G, making confusing the interpretation of the results (Figure 1). 
Moreover, the obtained result was very different from Ding’s outcomes that provided a clear 











With the aim to further optimize the approach, LP sequences were modified. 
The main focus of this methods relies on the concurrent stabilization of the correctly matched 
reactions and destabilization of the mismatched ones. To trigger a greater destabilization of 
the non-specific reaction, two factors were investigated, such as the length of LP sequence 
and the position of the SNP site on the probes. Hence, two new LP sets were designed as 
follow: both were composed by 10 nucleotides, one with the SNP site located at the sequence 
center (set 2) and the other one with the SNP site at the 3’ end (set 3). A heterozygous sample 
was tested using the two different LP sets (set 2 and set 3) with the same reaction conditions. 
Figure 1. Real Time fluorescence detection of a heterozygosis sample using LP-A (red line) and LP-G (blue line) of 
LPs set 1. 
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As reported in Figure 2, the results obtained with set 2 were confounding (Figure 2a), while 
with set 3 both allele types were correctly identify (Figure 2b).  
 
 
Figure 2. Real Time fluorescence detection of a heterozygosis sample using LP-A (red line) and LP-G 
(blue line) of two primer sets: set 2 (a) and set 3 (b). 
 
Since the obtained results entirely relied on the LPs employed, all the tested primer 
sequences were compared: LPs employed in Ding’s study (set 1), set 2 and set 3. The main 
difference between these pairs of probes referred to the melting temperature. In particular, 
the difference in melting temperature between LP-A and LP-G of each couple of primers was 
assessed. As reported in Table 1, among LP-A and LP G of set 1 the melting temperature 
difference was 5.5 °C, while the melting temperature difference between LP-A and LP-G of 
set 2 was 6.1 °C and between LP-A and LP-G of set 3 was 3 °C. In view of these observations, 
the results were explained. Each couple of probes had the same length, but a diverse 
sequence, one presented G and the other one A nucleotides. Consequently, the two probes 
had a different T melting, since it is well known that Guanine is involved in three hydrogen 
bounds during the hybridization with Cytosine, while Adenine and Thymine are connected 
by only two hydrogen bounds.  
Therefore, the temperature required for separate the target and the probe sequences is 
higher for LP-G rather than for LP-A. For this reason, at the same reaction temperature, the 
percentage of the probe that is annealed to the target sequence is higher when in the 
sequence is present the Guanine instead of Adenine. Thus, the reaction performed with LP-
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G was more stable and, as a result, it was faster rather than the one performed with LP-A. 
Accordingly with this reading, all the other obtained results revealed clear. In particular, the 
melting temperature of LP-G of set 1 was higher in comparison with the one of LP-A, 
therefore, although both allele types were present in the reaction mix, the reaction 
performed with LP-G occurred faster rather than the one performed with LP-A (Figure 1). 
Moreover, the melting temperature difference between LP-A and LP-G of set 2 was even 
higher in comparison with the one of the first pairs of primers tested and biased towards LP-
G. As a consequence, the time of occurrence of the two reactions was varying presenting an 
even bigger time frame (Figure 2a). On the other hand, the melting temperature difference 
between LP-A and LP-G of set 3 was 3 °C, thereby, even if the reaction performed with LP-G 
was slightly accelerated, the time gap between the two reaction was relatively narrow 
(Figure 2b). 
For all these reasons, to reduce the unbalance due to the nature of nucleotides interactions 
in the DNA double helix, another primer set was designed. 
The fourth set of primers was designed equalizing the melting temperature of the two probes 
(A and G) at the cost of achieving two probes with different length. The resulting set 4 
presented a difference in melting temperature of 0.4°C. As hypothesized, the perfect overlap 
of the two curves was obtained, clearly allowing the genotyping of a heterozygous sample 
(Figure 3). In fact, in case of heterozygous sample even with different sequences both primers 
should be designed in order they potentially accelerate both reactions with the same rate.  
Overall these findings demonstrated that among all the considered factors, such as primer 
length and SNP position on the sequence, the melting temperature difference between the 
two probes had the strongest impact on reaction efficiency. Higher was the melting 
temperature difference between the pairs of probes, higher was the difference in time of 











Figure 3. Real Time fluorescence detection of a heterozygosis sample using LP-A (red line) and LP-G 
(blue line) of primer set 4. 
 
With the aim to simplify all the procedures to make this strategy suitable for a POC 
diagnostic test, the possibility to skip the dilution of the extracted DNA was considered. 
Since primers set 4 resulted the most performant, four volounteers were genotyped 
employing LP-A and LP-G of set 4 without equalizing the template concentrations. As 
reported in Figure 4, samples 2 and 4 resulted heterozigous, while samples 1 and 3 resulted 
 Table 1 
Primers sets Δ T melt between LP-A and LP-G (°C)    
Set 1 5.5 
Set 2 6.1 
Set 3 3 
Set 4 0.4 
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homozigous wild-type (AA) and homozigous mutant (GG) for the investigated SNP, 
respectively. In fact, in sample 1 the reaction performed with LP-A is accellerated rather 
than the one performed with LP-G suggesting that the investigated genome was 
characterized by the A variant in homozigosis (AA). On the other hand, in sample 3 the 
behaviour is inverted indicating the presence of the genotype homozigous GG. 
Although the fluorescent discrimination was clear, starting with a different amount of 
template resulted disadvantageous for the development of a colorimetric version of the 
assay. In fact, with these reaction conditions, it was impossible to select a precise time point 
corresponding to the moment when only the perfectly matched reactions occurred, while 
the non-specific ones not. For this reason and in order to avoid false positive results, for the 
development of a colorimetric assays is necessarily required that all the specific reactions 















Figure 4. Real Time fluorescence detection of four samples using LP-A (solid line) and LP-G (dashed line) of 
primer set 4 without diluting the templates. 
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LAMP is a very sensitive and fast amplification technique. For this reason, LAMP 
amplification efficiency had to be reduced in order to obtain a single-nucleotide 
discrimination. In fact, the amount of the reagents usually employed in the reaction mix of 
classical LAMP protocol are not convenient for this aim. The goal was to sufficiently weak 
both amplification reactions by modifying reaction conditions, including template and 
enzyme concentrations. In this way, it was possible to destabilize as much as possible the 
non-specific amplification, without losing the stabilization of the perfectly matched reaction.  
Therefore, with the purpose to obtain a large time frame that could ensure a reliable 
genotyping also with the colorimetric test, the effect of the template concentration factor 
on the discrimination efficiency was analyzed. 
10’000 and 5’000 copies for reaction as final concentration of the template were employed 
and the relative results were compared. Three samples, one heterozygous and two 
homozygous (wild-type and mutant) DNA, were tested to compared each reaction 
condition.  
As showed in Figure 5 and 6, the main effect of the progressive reduction of the template 
amount was the retardation of non-specific reactions. In particular, it was observed that in 
both reaction conditions the perfectly matched reactions occurred almost simultaneously 
after 35/40 minutes. Otherwise, the time of occurrence of the non-specific reactions resulted 
fluctuating. Overall, employing 10’000 copies for reaction the resulted time gap between the 
fast and slow reactions was 20/30 minutes (Figure 5) while reducing the template amount the 

































Figure 5. Real Time fluorescence genotyping of three samples using LP-A (solid line) and LP-G (dashed line) of 
























These findings suggested that to enhance the differences between the times of occurrence 
of the two reactions is important to reduce the reaction efficiency. In particular, the 
Figure 6.  Real Time fluorescence genotyping of three samples using LP-A (solid line) and LP-G (dashed line) of 
primer set 4 using the template final concentration of 5’000 copies for reactions. 
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weakening of the reactions would lead to a greater impairment of the non-specific 
amplifications.  
Therefore, to further disadvantage the mismatch annealing, standard enzyme concentration 
was reduced of 30% (from 160 U/ml to 112 U/ml). Firstly, 112 U/ml as enzyme final 
concentration was tested in combination with the final concentration of template of 5’000 
copies for reactions. As a result, all the perfectly matched reactions occurred at the same 
time but with a slight delay (time of occurrence: 40 minutes) and the time gap between the 











































Figure 7. Real Time fluorescence genotyping of three samples using LP-A (solid line) and LP-G (dashed line) of primer 




Then, a further reduction of the template concentration was tested (1’000 copies for 
reactions) in combination with the reduced enzyme concentration (112 U/ml). With these 
conditions, the best results in terms of time frame was observed gaining a difference of 40/45 
minutes between the time of insurgence of the fast and slow reactions (Figure 8). 
In particular, all the specific reactions occurred with the same rate after about 50 minutes 
while the non-specific ones occurred after 90 minutes. These findings allowed a clear allele 
discrimination and guaranteed reliable results. Moreover, they are promising for the 
development of the colorimetric version of the assay. In fact, with these conditions a precise 
time point is easily identifiable and, most important, given the intrinsic characteristics of the 
assay, the not occurrence of false positive results is assured.  
Finally, to confirm the result, eight people were genotyped. Interesting, the result was highly 







































Figure 8. Real Time fluorescence genotyping of three samples using LP-A (solid line) and LP-G (dashed line) of 
primer set 4 using the template final concentration of 1’000 copies for reactions and reduction of 30% of the 






Figure 9. Real Time fluorescence genotyping of eight people using LP-A (solid line) and LP-G (dashed 
line) of primer set 4 using the template final concentration of 1’000 copies for reactions and 
















2.3 Material and methods 
 
DNA Extraction from saliva samples 
DNA was extracted from saliva samples using the following protocol. 1mL of saliva was 
mixed and 4 mL of Phosphate Saline Buffer (PBS) were added. The sample was centrifuged 
at 1800 rcf for 5 minutes at 4°C and the surnatant was discarded. 1 mL of milliQ water was 
added to the pellet, the sample was mixed, collected in a safe lock tube and centrifuged at 
12000 RPM for 5 minutes at 4°C. The surnatant was discarded and 150 μL of saliva 
Pretreatment Buffer, composed by PBS and EDTA were added. This buffer allowed to thin 
the saliva sample and to inactivate nuclease enzymes. 
Sample was mixed at 500 RPM for 30 minutes at 56°C. Then, sample was mixed using a 
Vortex Mixer (VWR International SRL, Milano, Italy). Subsequently the sample was mixed at 
500 RPM for 8 minutes at 100°C. 
Finally the sample was centrifuged at 12000 RPM for 5 minutes at 4°C. The resulting 
surnatant contains the extracted ssDNA.  
100 μL of the extracted ssDNA was collected and the concentration was measured using 
Nucleic Acid quantification tool of NanoDrop 2000c UV-visible Spectrophotometer (Thermo 
Fisher Scientific, Waltham, MA, USA). DNA concentration was converted from ng/μL to 
copies/μL using DNA copy number calculator tool of Thermo Fisher Scientific website 3. 
Finally, samples was diluted in MilliQ water at the desired final concentration. 
 
Primer Design for the optimization of PE-LAMP strategy 
Primer sequences for the optimization of PE-LAMP strategy were designed in collaboration 
with Dr.ssa Paola Cecere of the NanoBioInteractions&NanoDiagnostics Group.  
 
Optimized fluorescent-based LAMP Reaction for PE-LAMP  
LAMP reactions were performed in 25 μL of a mixture containing 1.6 μM each of inner 
primers, 0.4 μM each of outer primers, 0.8 μM of loop primers (Integrated DNA 
Technologies, Coralville, IA, USA), 1 M of betaine (VWR International SRL, Milano, Italy), 2.5 
μL of 10X LAMP buffer (200 mM of Tris-HCl, 100 mM of (NH4)2SO4, 20 mM of MgSO4, 500 
mM of KCl, and 1% v/v Tween 20), 2 mM of MgSO4, 0.8 mM each of dNTPs (Promega, 
Madison, WI, USA), 0.112 U/μL of Bst 2.0 WarmStart DNA Polymerase (New England 
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BioLabs, Ipswich, MA, USA), and 5 μL of DNA template at the concentration of 200 copies/μL 
of the extracted DNA. DNA-free LAMP reactions were included as negative controls. 
Amplification reactions were performed using forward and backward inner primers (FIP and 
BIP), forward and backward outer primers (F3 and B3), and one loop primer (LP-A or LP-G). 
For real-time fluorescent LAMP, 1/50,000 diluted SYBR Green (Thermo Fisher 
Scientific,Waltham, MA, USA) was pre-added to the reaction mix. Real-time amplifications 
were performed on an Applied Biosystem real-time instrument (Thermo Fisher 





















In conclusion, a state-of-art strategy for single-SNP genotyping was optimized combining it 
with a simple and rapid DNA extraction from saliva samples. The optimized method, 
exploiting LPs as allele discriminating primers, allowed a precise detection of the allele type 
present in the sample, resulting in a large difference in terms of times of occurrence. 
Moreover, the optimized approach resulted promising for the development of an efficient 
colorimetric test, ensuring the avoidance of false positive results. The possibility to develop 
the colorimetric version of the assay coupled with a simple and portable instrumentation that 
is the only need for the performing of the test are ideal for on-site diagnostics.  
The model case studied enabled to acquire a deep knowledge of the variables that mostly 
influence the resulted discrimination. Such acquired expertise, opened the perspective for 
the development of tests for SNP genotyping with possible real applications in relevant 
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A naked-eye assay for varietal traceability of durum wheat  
 
3.1 Introduction 
The results obtained in the present chapter have been published in Foods 2020, 9(11), 1691; 
https://doi.org/10.3390/foods9111691 with the title “A Fast, Naked-Eye Assay for Varietal 
Traceability in the Durum Wheat Production Chain” authored by Giulia Cibecchini, Paola 
Cecere, Giorgio Tumino, Caterina Morcia, Roberta Ghizzoni, Paola Carnevali, Valeria Terzi 
and Pier Paolo Pompa.  
Food traceability currently has a key role in the agri-food sector, bringing many benefits to 
both industries and consumers, such as supply chain optimization, improvement in food 
safety and quality, and an increase in controls and in the consumers’ confidence. Over the 
years, specific regulations and stringent controls have been introduced in several countries 
with different level of stringency to ensure food quality and safety and safeguard 
consumer’s health and rights. In particular, food traceability is regulated by several laws that 
demand to track “one step back” and “one step forward” of the supply chain 1. Italian pasta 
market, for example, is regulated by the Law n.580 of 1967 and by the subsequent Decreto 
del Presidente della Repubblica 41, 5 March 2013 2, 3. In such dispositions the use of durum 
wheat (Triticum durum) for pasta production was declared mandatory specifying that a 
contamination with Triticum aestivum species must not exceed the 3% maximum level. In 
fact, Durum wheat features, such as the gluten composition and the hard caryopsis make it 
more suitable for pasta production rather than common wheat 4 . Mandatory traceability 
actions are flanked by voluntary ones, characterized by the identification of standards 
related, for example, to the valorization of traditional food products and local economy 
development 5. At the industrial level, pasta for example is commonly made by mixtures of 
different durum wheat cultivars of Triticum durum wheat. At the same time, there is an 
increasing presence in the market of high-value mono-varietal pasta from both local 
producers and industrial ones. In such productions, there is great interest in developing a 
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voluntary traceability system to identify specific varieties along the production chain. The 
worldwide-spread pasta producer industry, Barilla, normally stipulates cultivation contracts 
with a restricted range of varieties, used as mix for pasta production. However, there is a 
special line, the Aureo wheat that is singularly used in the production. Among all the 
varieties of durum wheat, Aureo is considered one of the “top quality” since it has high 
protein and gluten content 6. Beside the peculiar characteristics of the variety that permits 
to raise the quality of pasta products, Aureo is cultivated in Italy, boosting this way Italian 
market and reducing import 7. 
Varietal fingerprinting approaches have been developed from mainly to protect intellectual 
property (IP) of wheat variety to guarantee plant breeders’ rights (PBR). Distinctness, 
uniformity, and stability are among the basic requirements for a variety. The traditional 
morpho-physiological descriptors, collected during the whole plant life cycle, are classically 
used for such evaluation purposes. In a further step, morphological descriptors have been 
flanked by biochemical markers, e.g., the isoforms of seed storage proteins. Such markers 
can be informative when applied to the grains, but are not effective on transformed 
products, in which technological processes can impair the proteins’ integrity. The 
subsequent advancement in varietal fingerprinting was based on the introduction of DNA 
markers that are independent of the environmental influence and available in theoretically 
unlimited numbers. 
Many classes of DNA molecular markers have been developed, ranging from inter simple 
sequence repeats (ISSRs) to amplified fragment length polymorphism markers (AFLP) and 
random amplified polymorphic DNA (RAPD), as reviewed by Pasqualone, 2011 8. SSRs 
(simple sequence repeats), considered the second generation of molecular markers and 
characterized by a simple technique, high polymorphism rate, and robustness, have been 
widely employed in wheat 9, 10. SNPs (single-nucleotide polymorphisms) are the third 
generation of molecular markers, with several advantages, including high frequency across 
the whole genome, ease of detection, and cost efficiency 11. 
Classical techniques for SNP genotyping was described in Chapter 1. In particular, for the 
wheat genome, SNP arrays are available and permit the identification of 9000 to 90,000 
polymorphisms 12, 13, 14. Moreover, with the development of next-generation sequencing 
(NGS) technology, increasing numbers of SNPs have been discovered, building the basis for 
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the development of diagnostic SNP barcodes 15. Now, the “universalization and 
minimization of SNP number without compromising identification accuracy is the major 
challenge in development of varietal profile by rapid genotype assay”, as reported by Singh 
et al., 2019 16. 
However, classical methods are time consuming, expensive, and require costly 
instrumentations and specialized personnel, limiting their practical applicability for quality 
control screenings in the food supply chain. A rapid, portable technique for SNP 
discrimination would thus be of great industrial interest.  
In pasta industry, both at industrial and local level, is very important distinguish among 
breeds trough the study of DNA to ensure a correct labelling of end-products valorizing the 
production and detecting fraud. In particular a greater advantage would be to be able to 
estimate the purity levels of the wheat grains delivered to the mill as Aureo variety, and 
consequently the pureness of the semolina derived by it. Additionally, inside an industrial 
reality, the possibility to have a tool for rapid screening a large number of samples provide, 
as advantage, the promptness of the acceptance (or not) of batches of grains at the time of 
delivery.  
Indeed, this thesis work is focused on the necessity, mainly industrial, of having a fast and 
reliable method for wheat grains and semolina control through the detection of a single 
SNP. The selected SNP was chosen not only because it is considered a rare variant, but also 
because it is private of only one variety among the grains covered by the contracts 
stipulated by Barilla. 
Therefore, the strategy optimized in chapter 2 was applied to address this specific 
requirement of pasta industry. The strategy was proven to be suitable for a portable 
platform and was demonstrated to be efficient in genotyping wheat cultivars. In particular, 
was able to detect the presence of Aureo, but also to discover substitution and adulteration 






3.2 Results and discussion 
The rapid and simple approach described in chapter 2 was applied to address an interesting 
case, relevant for industrial settings. In particular, the optimized single-SNP discriminating 
strategy was applied to reveal the presence of Aureo durum wheat in pasta products and to 
detect the possible adulteration of the declared mono-varietal products with other less 
precious ingredients.  
The results of the following work have been published. The project was performed in 
collaboration with the research group Dr. Valeria Terzi of Council for Agricultural Research 
and Economics, Research Centre for Genomics and Bioinformatics, and with Barilla S.p.A 
Company. 
The aim of the work is to provide an efficient tool for Barilla Company quality control area. 
This study led to identify a single relevant SNP as marker for the varietal discrimination. For 
this aim, 29 selected cultivars were analyzed with the DArTseq methodology. The analysis 
produced a set of 20198 good-quality SNPs (with a percentage of missing values below 
25%). Two replicate per variety were performed in order to reduce the risk to select a 
private SNP allele by a genotyping error. The average genetic distance between two 
replicates was 98.5% (simple matching), suggesting a genotyping error rate of 1.5% on 
average. A set of 11 candidate SNPs carrying a private allele of Aureo was identified, with 6 
of them presenting no missing values. The SNP marker for discrimination of Aureo was 
selected among those 6 SNPs with complete genotypes. The selected SNP was proven to be 
peculiar only for the Aureo genotype of durum wheat. 
Starting from the identification of this discriminating SNP, the SNP-sensitive detection 
method described in the chapter 2 was adapted and extended for the rapid and on-site 
authentication of Aureo durum wheat in food raw materials. 
As explained in chapter 2, the design of loop primers (LPs) has a pivotal role in this strategy. 
The criterion for SNP discrimination is based on the designing of two different LPs: one 
perfectly matched with the genome of one cultivar and the other one complementary to the 
sequence peculiar of all the others cultivars. In this strategy, the length of LPs is shorter than 
the one used in standard LAMP protocols. In particular, the approach relies on the 
stabilization of the annealing between short LPs and the perfectly complementary sequence, 
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while the non-specific one is disfavored. LPs act as accelerating primers, speeding up the 
onset of the amplification. Hence, the reaction in which the LP is perfectly hybridized will be 
properly enhanced.  On the contrary, due to the short LP length, at the reaction temperature 
the single mismatch will influence the thermal stability of the primer-target annealing, 
causing the primer melting and a relevant amplification delay (Figure 1).  
The genetic variation G>T is located on chromosome 7A of durum wheat genome. Hence, 
Aureo presents the polymorphic base T (G>T), while all the other cultivars are characterized 
by the nucleotide G, located at the same position. 
LPs were constructed as the following: LP-T, complementary to the SNP that identifies 
Aureo variant, and LP-G, perfectly matching the SNP distinctive of all of the other durum 
wheat varieties. This was sufficient for developing our single-SNP approach, which aimed at 
the discrimination of a variety within a relatively small panel. Such an approach would be 
very suitable for specific industry requirements. However, the genotyping effort required to 
identify a private SNP allele might be higher in situations with a larger panel of varieties or 
lower genetic diversity. To overcome this issue, a multi-SNP assay could be developed, since 
a private allele can be tagged more easily using more than one SNP. 
Each sample was tested with two reactions performed in parallel. The two reactions differed 
only for the LP. Since the single mismatch located on a short primer significantly impairs the 
annealing reducing the amplification rate, the two reaction will behave differently. 
The results of the SNP-sensitive LAMP reactions on real wheat samples was performed in 
Real-Time following the fluorescent emission of SYBR green I dye that intercalating to the 
dsDNA. The increase of the fluorescent emission is directly proportional to the amount of 
LAMP product. The amplification curve related to the reaction performed with the Aureo 
variant had a perfect annealing when performed with LP-T, so in this case, the amplification 
was properly enhanced. The exponential fluorescent signal related to the accelerated 
reaction, in fact, emerged after 40 minutes. On the other hand, with the same template, the 
reaction performed with LP-G was destabilized and significantly delayed (Figure 2a). 
The resulting time gap between the two amplification curves was about 40 min, clearly 
allowing the discrimination. 
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Conversely, the reactions performed using Marco Aurelio, another genotype of durum 
wheat taken as example, revealed the inverted behavior, with similar high temporal 
discrimination between the accelerated/matched (G) and non-matched (T) reactions. This 
result demonstrated that, in this configuration, a single mismatch can properly modulate 
the amplification efficiency of LAMP; consequently, it is possible to identify one specific 
durum wheat cultivar with high discrimination effectiveness (Figure 2b). 
 
 
Figure 1. Schematic representation of the hybridization of LPs to amplicon loops from durum wheat 
cultivars. During the exponential phase of LAMP reaction, the perfect match between LP-T and the 
complementary region on the Aureo intermediate loops accelerates the amplification, while the 
presence of the single mismatch between LP-T and G-variant amplicon loops causes the short primer 
destabilization and a significant reaction delay (a). On the contrary, for LP-G-mediated reactions, the 
perfect match between LP and the complementary region on the target is achieved in case of the 
presence of a G-type variant. Consequently, in case of the presence of a G-type variant the reaction is 







Figure 2. Real-Time fluorescence detection of genotype od durum wheat. LAMP reaction with LP-T 
(red line) and LP-G (blue line) of Aureo genotype (a) and one G-type variant genome (Marco Aurelio) 
(b). The time gap between fast and slow reactions is ca. 40 minutes. All the reactions were performed 
at 63 °C. 
 
To evaluate the reliability of the technique in a real scenario of quality control, 13 durum 
wheat cultivars were tested. Interestingly, the method was able to efficiently discriminate 
all of the 13 tested cultivars of wheat versus Aureo with an average time gap of 35-40 
minutes (Figure 3). Moreover, it is important to notice that, for all the samples tested, the 
time gap was nearly constant among all the tested cases and the time of occurrence of the 
accelerated reactions was constant. Therefore, this method resulted effective in the 
identification of a substitution of Aureo with another variety, allowing the detection of food 





Figure 3. Real-time fluorescence detection of 13 genotype of durum wheat. LAMP reactions with LP-T 
(red lines) and LP-G (blue) of Aureo and G-type variants (Aureo: dashed lines). The time gap between 
all the fast and all the slow reactions is 35-40 minutes. All the reactions were performed at 63 °C. 
 
Adulteration of food component with less valuable raw materials is considered a fraud as 
well as the substitution of food with undeclared ingredients. 
Therefore, a more complex scenario of food fraud, in which the Aureo species is adulterated 
(mixed) with another variety, with different levels of contaminations was investigated. This 
is important in industrial settings to guarantee the mono-varietal nature of some 
productions.  
To this purpose, different mixtures of Aureo with decreasing contaminations of a G-type 
variant (from 50 to 10%) were prepared to probe the sensitivity of the strategy to also 
detect minor adulterations. In this case, Babylone cultivar was used as representative of all 
the other genotypes of durum wheat. 
As reported in Figure 4, the method can effectively discriminate the 50/50 (Aureo/G-type) 
mixture, with the two reactions displaying similar efficiency. In such a case, the two 
reactions both behave like accelerated reactions, because the half amount of template of 
each cultivar is sufficient for the optimized functioning of the amplification (Figure 4c). 
Overall, the mixture appeared as a heterozygous sample. Comparable results were obtained 
with a 25% contamination with the G-type variant (Figure 4b). Although the amount of G-
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type genome was lower, the reaction with LP-G worked efficiently, exhibiting a negligible 
delay. Interestingly, our LAMP test was also able to discriminate an adulteration with the G-
type variant as low as 10% (Figure 4a). In this latter case, we observed a small delay of the 
LP-G reaction due to the significantly lower (10%) amount of G-type variant present in the 
mixture. 
However, the test behaved very differently with respect to the result obtained with 100% 
pure Aureo mixture, overall indicating that the proposed strategy enables accurate 
discrimination of relevant adulterations, including both substitution and mixing of wheat 




Figure 4. Real-time fluorescence detection of a simulated adulteration, in which a sample of Aureo 
was mixed with different proportions of a G-type variant (Babylone). (a) 90% of Aureo with 10% of G-
type variant; (b) 75% of Aureo with 25% of G-type variant; (c) 50% of Aureo with 50% of G-type 
variant. The LAMP reactions were performed with LP-T (red line) and LP-G (blue line) at 63 °C. 
 
Both the large time gap, together with the same time of onset of the curves related to the 
accelerated reactions, were important starting points for the development of the 
colorimetric configuration of this assay, based on a naked-eye detection of the results. 
Among the others, colorimetric strategies offer excellent platform to provide fast, on-site 
and cost-effective diagnostic tests, thanks to the minimal instrumentation required, as a 
simple portable heater device. 
As explained in Chapter 1, incorporation of nucleotides on the newly synthetized DNA 
strand by DNA polymerase activity leads to the release of hydrogen atoms. Therefore, 
during the amplification the pH of the reaction environment drops. As already reported in 
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literature, the decrease of pH value during the amplification can be exploited to obtain a 
color change. Indeed, a colorimetric interpretation of the results is possible pre-adding a pH-
sensitive dye that could provide a clear color change of the reaction tubes upon target 
amplification 18, 19. 
For these reasons, LAMP reaction was performed pre-adding to the reaction mixture the 
Cresol Red dye, which shifted from purple to yellow while the pH decreases from 8.8 to 7.2. 
In this way, at the starting pH value, the solution color is purple. In presence of target, the 
target amplification causes a solution color shift from purple to yellow, indicating that LAMP 
products have reached a significant concentration, and suggesting that the exponential 
reaction had started in an early stage. On the contrary, the solution keeps the purple color. 
Hence, in the SNP-sensitive LAMP assay, stopping the amplification at a specific time point, 
the positive results (yellow) corresponds to the accelerated reaction, while the negative 
results (purple) represents the amplification reaction that could not reached a proper stage 
and the sufficient amount of hydrogen ions, required to trigger the color change. In 
particular, since the fluorescent-based findings showed that all the fast reactions occurred 
after 30/40 minutes, while the slow ones arose almost after 60 minutes, it was considered 
to stop the colorimetric reaction at 1 hour in order to obtain the color change only in case of 
the accelerated reactions. 
In line with previous experiments, for the same target two reactions were carried out: one 
adding LP-T (tube A) and one adding LP-G (tube B); all the reactions were performed at 63°C 
for 1 h. As reported in the scheme in Figure 5a, the combination of the yellow/purple colors 
of the two reactions performed in parallel allowed detecting the possible scenarios, i.e., 
pure Aureo, the presence of contaminations (cultivar mixing), or full substitution. 
Colorimetric reactions were performed using as template 100% of Aureo genotype, 100 % of 
G-type variant and genome mixtures of both. In particular, different proportion of 
contaminant cultivar were tested, in particular 50%, 25% and 10% of G-type variant (figure 
5b).  In the case of the pure Aureo cultivar, the reaction performed with LP-T turned yellow 
(positive result), while the reaction performed with LP-G remained purple (negative result) 
(Figure 5b, sample 1). On the contrary, the full substitution of Aureo with a G-type variant 
exhibited the inverted result, with tube A appearing purple and tube B yellow (Figure 5b, 
sample 5).  Interestingly, all of the adulterated samples with different levels of 
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contaminations (down to 10% adulteration) were clearly detected, with both of the tubes 
exhibiting yellow color (samples 2–4) due to the amplification of both genotypes of durum 
wheat.  As well as the tests performed in real time, all the mixtures including the 
adulteration with a G-type variant genome at 10%, were detected with a good sensitivity. 
Moreover, this strategy was proven to be specific and had enough sensitivity for quality 




Figure 5. a) Scheme of the colorimetric test displaying the possible yellow/purple color combinations: 
pure Aureo cultivar (yellow/purple), adulterated mixture with G-type varieties (yellow/yellow), or 
fully substituted product (purple/yellow). (b) Colorimetric detection of possible adulteration cases of 
Aureo with another durum wheat cultivar (here Babylon as an example). LAMP reactions with LP-T 
(tube A) and LP-G (tube B) were all performed at 63 °C for 1 h. From left to right, targets were 
composed by 100% of Aureo variant of wheat (sample 1), then mixtures of Aureo and G- type variant 
(from 10 to 100%, samples 2-5), and negative control (sample 6). 
 
To completely validate our system, a more complex case of adulteration was tested, 
employing a mixture composed by three cultivars. In particular, the mixture was composed 
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by Aureo and two different G-type varieties of wheat, Babylone and Marco Aurelio 
representing an adulteration ranging from 50 to 10% of total contaminations. 
Remarkably, also in this case, the strategy revealed its high specificity, being able to 
correctly identify the different genotypes in a complex mixture and even in the situation in 





Figure 6. Colorimetric detection of a complex adulteration of Aureo with two G-type wheat variants. 
LAMP reactions with LP-T (tube A) and LP-G (tube B) were all performed at 63 °C for 1 h. From left to 
right, targets were composed of 100% Aureo variant, then mixtures of Aureo and two G-type variants 












3.3 Materials and methods 
 
Plant material and DNA extraction 
The following 28 durum wheat cultivars were used: Iride, Rusticano, Saragolla, Odisseo, 
Maestrale, Bronte, Antalis, Fabulis, Core, Svevo, Orizzonte, Aureo, Achille, Monastir, 
Claudio, Tirex, Pigreco, Normanno, Marco Aurelio, Relief, Miradoux, Babylone, Simeto, 
Anvergur, Navigator, Levante, Kyle, and Kronos. Moreover, the tetraploid Triticum 
turanicum, variety QK-77 (traded as Kamut®), was included in the analysis. All of the 
cultivars were certified foundation seeds produced directly from the breeder responsible for 
their maintenance in purity. Ten certified seeds of each variety were sown in duplicates in 
pots, and the foliar tissues were harvested at the three-leaves stage. DNA samples were 
isolated and purified using the cetyl trimethyl ammonium bromide method [17]. The quality 
check, quantification, and concentration adjustment were accomplished with a 
NanoDrop2000C Spectrophotometer (Thermo Fisher Scientific, Monza, Italy). The 
concentration of each sample was adjusted to 50 ng/μL. Two biological replicates of DNA 
extracts were used for each variety. 
 
Genotyping by sequencing and SNP data analysis 
Purified DNA samples (1 μg for each sample) were sent to Diversity Arrays Technology Pty 
Ltd. (http://www.diversityarrays.com/, Canberra, Australia) for sequencing, and SNP marker 
identification was done by DArTseq genotyping. Sequences of the genomic representations 
were obtained on a HiSeq2500 instrument. 
The set of SNP markers generated by DArTseq was curated, removing markers with more 
than 25% of missing values (null alleles were considered as missing). SNPs with low frequent 
alleles were kept in the dataset to allow the research of private alleles of Aureo. This 
resulted in a dataset containing 20,198 SNPs and 58 samples (two genotyping replicates for 
each cultivar). After marker curation, all samples had a percentage of missing values below 
10% and a percentage of heterozygous calls below 12%. Genetic distances were calculated 
based on simple matching. A custom R script was used to select SNPs with no missing values 
and a private allele of both replicates of Aureo. Candidate SNPs were mapped on the durum 
wheat genome sequence [18] by BLAST (Basic Local Alignment Search Tool). Starting from a 
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panel of 11 candidates, an SNP mapped on chromosome 7A was selected for further 
analyses.  
 
Primer design for LAMP strategy 
LAMP primers were designed from the 7A chromosome of durum wheat. Primer sequences 
are shown in Table 1: 
 













Fluorescent-based LAMP reactions 
LAMP reactions were performed in 25 μL of a mixture containing 1.6 μM each of inner 
primers, 0.4 μM each of outer primers, 0.8 μM of loop primers (Integrated DNA 
Technologies, Coralville, IA, USA), 1 M of betaine (VWR International SRL, Milano, Italy), 2.5 
μL of 10X LAMP buffer (200 mM of Tris-HCl, 100 mM of (NH4)2SO4, 20 mM of MgSO4, 500 
mM of KCl, and 1% v/v Tween 20), 2 mM of MgSO4, 0.8 mM each of dNTPs (Promega, 
Madison, WI, USA), 0.112 U/μL of Bst 2.0 WarmStart DNA Polymerase (New England 
BioLabs, Ipswich, MA, USA), and 5 μL of DNA template at the concentration of 5 ng. DNA-
free LAMP reactions were included as negative controls. Amplification reactions were 
performed using forward and backward inner primers (FIP and BIP), forward and backward 
outer primers (F3 and B3), and one loop primer (LP-T or LP-G). For real-time fluorescent 
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LAMP, 1/50,000 diluted SYBR Green (Thermo Fisher Scientific,Waltham, MA, USA) was pre-
added to the reaction mix. Real-time amplifications were performed on an Applied 
Biosystem real-time instrument (Thermo Fisher Scientific,Waltham, MA, USA) with StepOne 
Software v2.3 at 63 °C. 
 
LAMP reactions for colorimetric assay 
LAMP colorimetric reactions were performed as reported above, using 1 M of betaine (VWR 
International SRL, Milano, Italy), 2.5 μL of 10X LAMP buffer (100 mM of (NH4)2SO4, 20 mM 
of MgSO4, 500mMof KCl, and 1% v/v Tween 20), 2mMof MgSO4, 0.8mMeach of dNTPs 
(Promega, Madison, WI, USA), 0.112 U/μL of Bst 2.0 WarmStart DNA Polymerase (New 
England BioLabs, Ipswich, MA, USA), and 5 μL of DNA template at the concentration of 5 ng. 
DNA-free LAMP reactions were included as negative controls. For visualized detection, 0.06 
mM of Cresol Red (Sigma-Aldrich, St. Louis, MO, USA) was pre-added to the reaction mix. 
The amplification efficiency was verified by color changing of the reaction mix. Colorimetric 
LAMP reactions were performed on a T100 Thermal Cycler (BIO-RAD, Hercules, CA, USA) at 














Food identification and traceability are crucial step to ensure the quality of the production. 
Nowadays, rapid and accurate on-site tests are emerging to flank the commonly used 
techniques for genetic traceability. In this framework, a single-SNP discriminating strategy 
was designed to correctly identify mono-varietal products. Moreover, a colorimetric version 
of the assay, able to discriminate by naked-eye inspection, the purity or the adulteration of 
Aureo with any G-type variants of durum wheat was developed. The use of isothermal 
amplification, the LAMP, together with the visualization of the readout by a color change 
obtained in a short time, make this approach suitable for portable testing. This approach 
fulfill the need for a rapid and reliable pre-screening of food raw material in pasta industries 
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A fast, fluorescent-based predictive test for the detection of 
genetic predisposition to lactose intolerance 
 
4.1 Introduction  
Lactose is a disaccharide composed by glucose and galactose. Lactase enzyme, which is 
located in the small intestine, hydrolyzes lactose, introduced with diet, into its two 
components.  
In case of deficiency of lactase enzyme, as in lactose intolerance, lactose is digested by 
bacteria inside the colon. Therefore, lactose intolerance symptoms are related to the 
fermentation of lactose by colonic bacteria that produces gas, causing the consequently 
intestinal disorders such as nausea, bloated feeling, intestinal cramps, meteorism and 
diarrhea. 
Lactose intolerance can be classified in the following types: Congenital lactase deficiency 
(CLD), Developmental Lactase Deficiency, Lactase Non-Persistence (NPL) or Primary 
Hypolactasia and Secondary Lactase Deficiency. CLD is a rare inherited disorder that affect 1 
on 60,000 children in the word with a particular prevalence in the Finnish population. Five 
nonsense mutations have been founded as the cause of this severe gastrointestinal disorder. 
In particular, these mutations are located on the coding region of the lactase gene impairing 
irreversibly the final function of the encoded enzyme 1. Another form of lactose intolerance 
is the Developmental Lactase Deficiency, which is a condition that occurs in premature babies. 
In fact, lactase activity increases in fetus during gestation until birth. Therefore, prematurely 
born infants present a lactose intolerance related to the enzyme deficiency 2. However, in this 
case lactose malabsorption symptoms can be avoided by the action of particular species of 
colonic bacteria 3. Lactase Non-Persistence (NPL) or Primary Hypolactasia is the most common 
form of intolerance, and it is related to a downregulation of the enzyme after weaning until 
the adulthood when the Lactose activity is completely lost 4. Finally, the lactose intolerance 
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form called Secondary Lactase Deficiency generally is a reversible condition because it is a 
consequence of other diseases, such as Chron’s disease or infections that cause damages to 
the intestine 3. 
About 70 % of the world population presents Primary Hypolactasia. Its incidence is significant 
in South America, Africa, Asia and variable in Europe 5, 4, 6. In Italy, lactose intolerance 
prevalence is higher in the north and decrease gradually in the center and the south 7.  
There are several hypothesis at the basis of the evolutionary reason why this haplotype has 
been handed down over the centuries. One of these hypothesis is related to vitamin D, which 
is necessary for calcium absorption. Vitamin D is contained in milk. However, ultraviolet 
radiation penetrating into the epidermis can trigger vitamin D synthesis. This factor have led 
North European populations to be more dependent on dietary assumption of milk rather than 
South Europeans that are more exposed to sunlight, favoring the lactose persistence 
haplotype in the North  5. 
There are several diagnostics tools for identification of Primary Hypolactasia. The most 
common one is Lactose Hydrogen Breath Test (LHBT) that consists on measuring hydrogen in 
the patient’s breathes at regular intervals after lactose assumption 8. However, this exam can 
give false negative results related, for example, to antibiotic treatments or false positive 
results due to a surplus of intestinal bacterial flora. 
Another possibility are genetic tests that identify the genetic predisposition to lactose 
intolerance 9. Genetic predispositions rely on genetic factors that increase the chance of 
developing a particular disease throughout life. In particular, the presence of one or more 
gene polymorphisms coupled with predisposing environmental conditions and lifestyle 
increase the risk of the occurrence of a certain phenotype. Unlike monogenic disorder that 
are caused entirely by genetic factors, such as cystic fibrosis or alfa1-antitripsina deficit, in 
multifactorial disease, the disorder is the result of gene and environmental interaction. In fact 
diet, smoke, stress and others environmental factors play an important role in genetic 
susceptibility. 
The presence of a particular SNP upstream the lactase gene 1 locus, -13910C>T, has been 
identified as an indication of genetic predisposition for Primary Hypolactasia. This SNP is 
located on minichromosome maintenance complex component 6 (MCM6) gene, which is 
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adjacent to the lactase (LCT)  gene 10. MCM6 gene regulates the expression of LCT gene and 
causes the downregulation of lactase enzyme. The presence of the CC genotype in 
homozygosis is associated to Primary Hypolactasia. The heterozygosis variant CT is not strictly 
linked to the development of lactase non-persistence trait but it can predispose individuals 
to lactose malabsorption during periods of stress. Finally, the homozygosis variant TT is 
associated with Lactose Persistence phenotype 11. In Italy about 30% of individuals present 
CC genotype, 60% is heterozygous CT while only 10% has the TT genotype 12. However, the 
occurrence of lactose intolerance symptoms depends both on genetic traits and other factors 
such as, in this case, the dose of lactose assumed and the intestinal flora 5. As a consequence, 
CC individuals have to pay attention to manifestation of intolerance related symptoms and 
adapt their diet to prevent health concerns 13.  
Predictive genetic assays are commonly performed by specialized laboratories with a 
turnaround time for the analysis of about 7-10 days. Samples are collected through a blood 
draw or a mouth swab and the DNA is extracted from blood cells or from cells of mouth 
epithelium.  
An interesting possibility consist of portable predictive tests that could be potentially 
available in decentralized settings. Especially, a portable diagnostic tool could be at the 
disposal of Nutritionists to perform predictive genetic tests directly during specialist medical 
examinations. This could allow to intervene at an early stage introducing dietary changes in 
response to the genetic profile. 
In this thesis work, the rapid LAMP-based diagnostic strategy illustrated in chapter 2 and 3 
was adapted to the detection of -13910C>T SNP. The strategy was designed to be performed 
in a portable heater device able to read and record a fluorescent signal. This type of 
instrument is commercially available and it is significantly cheaper in comparison with the 
Real-Time PCR, which owes its complexity into the ability to carry out thermal cycles (Figure 
1). For LAMP applications, in fact, it is only required to reach and maintain one temperature.  
The strategy was designed with the aim to develop a non-invasive POC test. In fact, the 
starting material for performing the assay is a saliva sample, from which cells of the mouth 
epithelium are collected. Saliva is an easy collectible biological sample and its employment in 
diagnostic tests permits to increase patient compliance. Moreover, saliva can be collected in 
74 
 
a simple non-treated container. The use of such simpler instrumentation coupled with a non-
invasive approach, open the possibility to bring out predictive screenings from specialized 



















4.2 Results and discussion 
The optimized SNP-sensitive LAMP-based strategy resulted highly versatile and easily 
adaptable to other model cases involving a SNP-based discrimination. 
Indeed, the single-SNP discriminating method was further applied to a relevant case in the 
field of nutrigenetics: the diagnosis of the genetic predisposition to Primary Hypolactasia.  
Primary Hypolactasia is the form of lactose intolerance caused by a reduction of the 
production of lactase enzyme after infancy. However, some adults keep the ability to produce 
the enzyme throughout life. This trait is called Lactase-Persistence and it is associated to the 
presence of a SNP located on the MCM6 gene, called -13910C>T. 
In particular, the allele type (T) is associated with lactase persistence: individuals presenting 
this genetic variation (T) preserve the ability to digest lactose in the adulthood. On the 
contrary, the allele type (C) is associated with the intolerant phenotypes that cause health 
problems related to the lactose malabsorption.  
In this project, the genetic test for the predisposition to lactose intolerance was designed 
combining the SNP-sensitive LAMP-based strategy with a non-invasive sampling, using saliva 
specimen as clinical sample. In fact, DNA was extracted from buccal epithelium cells that are 
present in saliva. With the aim to develop a POC diagnostic platform, it was excluded to 
introduce complex DNA extraction methods (for example with magnetic beads or purification 
columns) in the test procedure. The extractive procedure had to be simple, rapid, and easy 
handled to be suitable for a portable approach. For this purpose, the extractive phase 
described in chapter 2 was optimized as following. The salivary sample was centrifuged using 
a low-cost benchtop minicentrifuge. The obtained pellet was undergone to a thermochemical 
lysis, and no further purification steps were performed. 
In the experimental investigation of the method efficiency, the extracted DNA was quantified 
through a UV-visible spectrophotometer and diluted at the final concentration of 200 
copies/μL. 5 μL of the diluted DNA were added to the LAMP reaction, without further 
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purification steps. The use of a raw DNA was feasible thanks to the intrinsic characteristics of 
LAMP that has a high tolerance to contaminants and matrix components 14. 
Overall, the here-used optimized protocol was faster in comparison with the extraction 
procedure used in the chapter 2, requiring only 15-20 minutes, and it can be performed by 
non-trained users. 
A future perspective for the optimization of the extractive phase of the test is to eliminate 
the dilution step of the extracted DNA. Optimizing the strategy in order to make it 
independent from the template concentration would allow to directly add the extracted 
template in the reaction mix, obtaining a completely portable assay, adaptable to 
decentralized settings.  
The here-proposed SNP-sensitive LAMP strategy required the optimization of primers 
sequences and reaction conditions. As explained in chapter 1, the reactions were performed 
employing only one loop primer (LP), forward or backward on the basis of the target sequence 
around the SNP site. In this case, two primer versions of LP backward were designed 
accordingly to the SNP. 
In this case, two Primers sets (set 1 and 2) were designed to be tested with the strategy. The 
two sets differed only for the discriminating LPs (LP1-C and LP1-T, LP2-C and LP2-T). For each 
set, LP-C was designed to detect the base that identify the genotype related to predisposition 
to lactose intolerance, while the LP-T was designed to be complementary to the polymorphic 
site. For each saliva sample, two reactions were performed in parallel, one pre-adding LP-C 
and the other one pre-adding LP-T, to ensure that the same target was examined with both 
probe types.  
In presence of a homozygous CC sample, the amplification reaction operated with LP-C will 
be accelerated, while the simultaneous reaction performed with LP-T will be delayed. The 
opposite reactions behavior will occur in presence of a homozygous TT sample. On the 
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contrary, since heterozygous CT individuals are characterized by the presence of one copy for 
each allele type, both reaction will be enhanced, generating two overlapped curves. 
Since the objective for the presented application is to develop a fluorescent–based detection, 
in this case amplification reactions were performed in Real-Time following the fluorescent 
emission of SYBR Green I that occurred as LAMP amplicons were synthetized. 
The aim of the strategy optimization phase was to achieve an unequivocal readout of test 
results, obtaining: 
- the maximum time gap possible between the fast and the slow reaction curves in presence 
of a homozygous sample; for this purpose, the two LPs must be able to accelerate the LAMP 
amplification only in presence of 100% match, and a relevant delay in presence of a single 
primer/target mismatch. 
- The perfect overlap of the two curves in presence of a heterozygous target; for this purpose, 
in presence of both allele types, the two LPs must show the same efficiency in amplification 
acceleration. 
- The fastest time of onset of curves, to achieve a rapid detection test. 
 For these purposes, the 2 primers sets were tested and compared. As shown in Figure 1, the 
primer set 1 operated a sufficient discrimination for homozygous samples (CC), however is 
was not able to provide the overlap of the two curves in the heterozygous case (TC), giving 
misleading results .   
Therefore, the primer design was optimized with the set 2, in terms of the SNP binding site 
on the probe and melting temperature value for both primers, in order to reproduce the same 
time gap when analyzing a homozygous sample and to achieve a similar amplification rate for 
the both reactions in case of a heterozygous sample. In particular, primer set 2 was designed 
as follow: the SNP binding site on the probe was shifted toward the center of the primer 
sequence and the melting temperature difference between the LP2-C and LP2-T was 
optimized. 
In this way, a greater improvement was obtained in managing heterozygous samples and an 
adequate time gap was achieved in case of a homozygous sample (Figure 2). Moreover, in 
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case of homozygous sample, the onset of the accelerated amplifications was more 














Therefore, the primer set 2 was selected and, giving the results of an high numbers of tested 
samples, further optimization to reaction conditions were introduced. 
Figure 1. Real-time fluorescence detection of homozygous CC (a) and heterozygous CT samples (b). 
LAMP reactions were performed with primer set 1. The same sample was tested twice and for each 
sample two parallel reactions using LP1-C and LP1-T were performed. The homozygous sample is 
characterized by the acceleration of the reactions performed with LP1-C, while the heterozygous 
sample, since both allele copies are present, is distinguished by the enhancement of both reactions. 
Figure 2. Real-time fluorescence detection of homozygous CC (a) and heterozygous CT samples (b). 
LAMP reactions were performed with primer set 2. The same sample was tested twice and for each 
sample two parallel reactions using LP2-C and LP2-T were performed. The homozygous sample is 
characterized by the acceleration of the reactions performed with LP2-C, while the heterozygous 
sample, since both allele copies are present, is distinguished by the enhancement of both reactions. 
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The objective was to obtain reliable and reproducible results that were independent from 
samples’ variability. In particular, reaction conditions were slightly modified, modulating the 
MgSO4 concentration and the enzyme concentration. 
Finally, the best result in terms of discrimination efficiency was obtained (Figure 3). 
In this case, a heterozygous and a homozygous CC samples were amplified with the primer 
set 2 with the optimized reaction conditions and at 61°C of reaction temperature. A control 
sample without the pre-addition of any LP was introduced. As reported in Figure 3a, in case 
of a heterozygous sample, both reactions were correctly enhanced with the same rate, 
indicating the presence of both allele type in the target sample. In case of a homozygous 
individual, the reaction where the LP perfectly matched to the nucleotide associated to 
lactose intolerance is significantly accelerated, indicating the genotype of the investigated 
sample (Figure 3b). Interesting the behavior of the reaction performed without including any 
LP is comparable to the one of the slow reaction. These results underlined the substantial 
effect played by LPs. In fact, a single mismatch located on a short probe can nullify the LP 




Figure 3. Real-time fluorescence detection of heterozygous CT (a) and homozygous CC 
samples (b). LAMP reactions were performed with primer set 2 composed by LP2-C (red line) 
and LP2-T (blue line). Amplification reaction of both heterozygous and homozygous samples 
without the pre-addition of any LP was performed (black line). The time gap between fast 





To confirm these results, 10 people were tested using the here-presented SNP genotyping 
assay. The 10 people to test were chosen randomly and their characteristics (e.g. sex, age, 
apparent lactose intolerance) were listed in Table 1. Observing the fluorescent based 
detection outcomes, the results were clear and can easily be interpreted. In case of a 
homozygous sample the two curves are sufficiently separated with a time gap ranging from 
12.5 and 15 minutes, while in case of heterozygous samples the two curves perfectly 
overlapped. Moreover, with this approach a reliable SNP detection is achieved within 1 hour, 
providing a significant advantage in comparison with the standard techniques (Figure 4). 
 
 
Patient Sex Age Lactose intolerance 
symptoms 
1 Female 28 No 
2 Female 36 No 
3 Female 33 No 
4 Male 36 Yes 
5 Female 36 No 
6 Female 29 No 
7 Female 26 Yes 
8 Female 31 No 
9 Female 35 No 
10 Male 30 Yes 
 





Figure 4. Real-time fluorescence genotyping of lactose intolerance predisposition for 10 
people. LAMP reactions were performed with primer set 2 composed by LP2-C (red line) and 
LP2-T (blue line). Heterozygous CT samples were detected by the correct enhancement of 
both reactions, while homozygous CC samples were identified by the acceleration of the 
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To validate the efficiency of the method, the test results were compared with the ones 
provided by a certified testing laboratory, Lifebrain.  
To perform the Lifebrain test, the test must be purchased online; a buccal swab is delivered 
at patient home. The patient self-collects the sample and sends back it to the specific 
laboratory where the genetic test is performed. The test results are provided with a 
turnaround time of 7 days.  
Interestingly, the results obtained with the optimized SNP assay, compared with results listed 
in the report from the testing laboratory, were validated with 100% of concordance (Figure 
5). Since homozygous TT individuals are poorly represented in the general population, among 






Figure 5. Comparison of Genotyping of 10 individuals for -13910C>T genetic variant with a 
laboratory analysis test performed by Lifebrain and with the SNP-sensitive LAMP-based test. 





4.3 Materials and methods  
Optimized protocol for DNA extraction from saliva samples 
DNA was extracted from saliva samples using the following protocol. 500 μL of saliva were 
collected in a safe lock Eppendorf tube and mixed with 1 mL of Phosphate Saline Buffer 
(PBS). Samples were then centrifuged at 6000 RPM for 10 seconds using Mini 
Microcentrifuge (Labnet International, Edison, New Jersey, USA) and the resulting 
supernatant was discarded. The pellet was suspended in 200 μL of Pretreatment Buffer and 
was mixed at 500 RPM for 10 minutes at 95°C using a ThermoMixer (Eppendorf, Milano, 
Italy). After this step, samples were mixed with using a Vortex Mixer (VWR International 
SRL, Milano, Italy) and then centrifuged for 1 minutes at 6000 RPM using Mini 
Microcentrifuge (Labnet International, Edison, New Jersey, USA). After centrifuge a pellet, 
composed by cells debris and proteins, resulted separated from the surnatant that contains 
the extracted ssDNA. Finally, sample concentration was assessed as described in Chapter 2 
and it was diluted in MilliQ water at the final concentration of 200 copies/μL. 
 
Primer design for LAMP strategy 
Primer sequences for the predictive test for lactose intolerance were designed by Dr.ssa 
Paola Cecere of NanoBioInteractions&NanoDiagnostics Group starting from the MCM6 
human gene. 
 
Fluorescent-based LAMP reactions for predictive test for the detection of genetic 
predisposition to lactose intolerance 
LAMP reactions were performed in 25 μL of a mixture containing 1.6 μM each of inner 
primers, 0.4 μM each of outer primers, 0.8 μM of loop primers (Integrated DNA 
Technologies, Coralville, IA, USA), 1 M of betaine (VWR International SRL, Milano, Italy), 2.5 
μL of 10X LAMP buffer (200 mM of Tris-HCl, 100 mM of (NH4)2SO4, 20 mM of MgSO4, 500 
mM of KCl, and 1% v/v Tween 20), 2 mM of MgSO4, 0.8 mM each of dNTPs (Promega, 
Madison, WI, USA), 0.80 U/μL of Bst 2.0 WarmStart DNA Polymerase (New England BioLabs, 
Ipswich, MA, USA), and 5 μL of DNA template at the concentration of 200 copies/μL of the 
extracted DNA. DNA-free LAMP reactions were included as negative controls. Amplification 
reactions were performed using forward and backward inner primers (FIP and BIP), forward 
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and backward outer primers (F3 and B3), and one loop primer (LP-C or LP-T). For real-time 
fluorescent LAMP, 1/50,000 diluted SYBR Green (Thermo Fisher Scientific,Waltham, MA, 
USA) was pre-added to the reaction mix. Real-time amplifications were performed on an 
Applied Biosystem real-time instrument (Thermo Fisher Scientific,Waltham, MA, USA) with 































An effective fluorescent-based SNP discriminating tool was developed and applied to an 
example of a clinically relevant nutrigenetic case, in particular, the genetic predisposition to 
lactose intolerance. The assay resulted effective in the discrimination of both homozygous 
and heterozygous patients starting from simple saliva samples. The test results were 
confirmed by the current reference assay performed by a specialized laboratory. In addition, 
a significant improvement of the turnaround time of the analysis was achieved. In fact, with 
the described optimized strategy a reliable results was obtained within 1 hour, while the 
ordinary lab test requires at least 7 days.  
Overall these findings opened the perspective for the development of a rapid and portable 
tool for identification of genetic-based predisposition to certain traits that could be associated 
to the intolerance to particular nutrients. This fast, low cost and easy-to-use assay, would turn 
genetic screening into analysis accessible to everyone. 
Moreover, such predictive tests would allow a rapid screening of patient’s genome, furnishing 
to the Nutritionist the information to recommend the appropriate diet to the patients.  
On the contrary, in case of a patient presenting gastrointestinal disorders and a genetic profile 
that does not suggest lactose malabsorption problems, Primary Hypolactasia could be fast 
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A fast, fluorescent-based pharmacogenetic assay for the 
detection of the 677C>T polymorphism on MTHFR gene 
 
5.1 Introduction 
Folate is the natural form of vitamin B9. As it is an essential nutrient, folate is not 
synthetized by human organism and have to be taken with diet. Several dietary sources are 
rich in folate, such as green leafy vegetables, beans, grains, eggs, pork and beef meats 1.  
Natural dietary folates are water-soluble and thermolabile. 
Folic acid is the synthetic form of vitamin B9, used as supplements and present in fortified 
foods. Folic acid is stable, more resistant to cooking procedures rather than folates and 









Folic acid undergoes to two modifications catalyzed by the Dihydrofolate Reductase (DHFR) 
enzyme prior to enter into the folate cycle. Finally, it has to be transformed into its active 
form, the 5-methyl-THF. 5-methyl-THF is then directed towards the biosynthesis of 




Figure 2. Folic acid metabolic pathway 4. 
 
 
Since folate is required for the biosynthesis of nucleotides and proteins and for the 
methylation process, it is essential in all the phases of fetal growth, such as implantation 
and organ development. Hence, folate supplementation during pregnancy is strongly 
recommended to reduce the risk of congenital abnormalities. In fact, the process for 
formation of central nervous system during embryonic development, the neurulation, can 
be impaired by a folic acid deficit that can lead to fetus malformation, such as Neural Tube 
Defects (NTD) 1. Moreover, the folate deficit can cause a high level of Homocysteine (Hcy) in 
the bloodstream, that is as well a risk factor for occurrence of NTD in embryos, recurrence 
of pregnancy lost and other pregnancy complications 5, 6. In fact, Hcy acts with a negative 
feedback mechanism limiting the physiological cells methylation process. In particular, DNA 
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methylation process is at the base of epigenetic modification of the DNA, influencing gene 
expression, which has a pivotal role in embryogenesis 7, 4. 
Foods fortified with folic acid has been introduced in several countries with the purpose to 
reduce the birth defects. In United States and Canada, for example, the fortification of food 
with folic acid is mandatory, while in Italy it is strongly recommended. As demonstration of 
the importance of folic acid supplementation, the consume of enriched products in United 
Stated and Canada has led to a significant decrease of the number of newborns with neural 
tube defects 8.  
The methylenetetrahydrofolate reductase (MTHFR) enzyme is involved in the folate 
metabolic pathway.  In particular, MTHFR enzyme catalyzes the reduction of 5,10-
methylenetetrahydrofolate (5,10-methylene-THF) to 5-methyltetrahydrofolate (5-methyl-
THF). MTHFR straddles between two metabolic pathways: folate cycle, which is committed 
to purine and pyrimidine synthesis, and methionine cycle, that is aimed at protein 
production (Figure 3). 5-methyl-THF and Hcy, through the action of the enzyme Methionine 
Synthase and using cobalamin (vitamin B12) as a cofactor, are transformed into Methionine, 
that is the starting step for protein synthesis. Methionine through S-adenosyl Homocysteine 
(SAM) is involved in methylation processes that are fundamental for several cell physiology 
processes, especially, for epigenesist and imprinting stages of embryo development (Figure 





Figure 3. The Folate cycle and the Methionine cycle 3 . 
 
 
Recently, a particular SNP located on MTHFR gene, the 677C>T genetic variation, has been 
identified. The most frequent allele presents the nucleotide C at the 677 position in the 
MTHFR gene, while the polymorphic allele at the same position has the nucleotide T 7. 
This gene variant encodes for a thermolabile variant of the enzyme characterized by a 
reduced enzymatic activity 9. In particular, in comparison with the wild type form CC, which is 
perfectly functional, the polymorphism in homozygosis TT leads to the production of an 
enzyme with a remaining activity of about 30% and the heterozygosis haplotype CT generates 
an enzyme with an activity of 65% 10.  
The presence of 677C>T genetic variant of MTHFR enzyme has a crucial importance for 
pregnancy concerns and congenital defects. Indeed, malfunctioning of MTHFR enzyme causes 
a reduction of the availability of the folate active compound, causing high plasma Hcy and a 
reduction of methionine synthesis, which are risk factors for pregnancy complications (Figure 
3) 7, 11, 12, 13.   
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Several studies reported that the folate concentration in the serum of women that present 
677C>T variant in homozygosis is lower when compared with women with the TC and CC 
genotypes even after folic acid supplementation 14. On the contrary, it has been reported in 
literature that homozygous CC subjects have a greater bloodstream concentration of 5-
methyl-THF, the active form of folic acid, in comparison with homozygous TT ones 15. 
The prevalence of 677C>T polymorphism in homozygosis ranges in Europe from the 8% in 
Germany to the 21% in Hispanic population. In Italy the homozygosis TT genotype frequency 
ranges from 18 to 25 % 11, 16, 17. 
The Recommended Dietary Allowance (RDA) of folate for lactating and pregnant women is 
600 μg/d 18, while women with MTHFR polymorphism are advised to assume up to 800 μg/d 
19.  
Folic acid, as well as all the other vitamins, should be taken in the right balance in order to 
avoid deficit and surplus that could be both harmful. In fact, excess of folate intake can lead 
to the development of the unmetabolized folic acid (UMFA) syndrome. At present, this issue 
is being debated, however, several health risks are associate to UMFA. In particular, it has 
been reported that UMFA can cause dysfunction of immune system. Additionally, it seems to 
play a dual role in carcinogenesis reducing cancer risk and promoting the growth of existing 
neoplastic lesions 20, 21, 22. In literature it is also reported that UMFA can lead to a pseudo 
MTHFR deficiency and to the downregulation of folate transporters presents in human 
intestinal cells. 23, 24 . Finally extra folic acid supplementation may also mask vitamin B12 
deficiency. People with a deficit of vitamin B12 and a surplus of folic acid never develop 
megaloblastic anemia, which is the main symptom of the lack of vitamin B12. Folic acid 
supplementation, in details, prevents the insurgence of vitamin B9 deficiency related 
symptoms. 
Due to all of these reasons, even if supplementation with folic acid in women with the 677C>T 
polymorphism is not sufficient to increase the plasma level of the metabolic active compound, 
an overdose of unmetabolized folic acid could be damaging.  
Thereby, the alternative supplementation consists of the reduced and methylated form of 
folates, 5-methyl-THF, that permits to bypass the MTHRF catalyzed step. This form can replace 
the classical folic acid supplementation in women with the polymorphism. Supplementation 
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with 5-methyl-THF provides several advantages for women who carry the genetic variation 
and it has been demonstrated that the administration of the active compound revealed 
efficient in increasing the plasma concentration of 5-methyl-THF 25, 26.  
Overall these findings seriously highlight the pharmacogenetic issue related to folic acid 
assumption. For these reasons, supplementation with a standard dose which is independent 
from patient genetic profile must be avoided. Information about the mother genotype should 
became a routine tests in order to select the right folate supplementation in accordance to 
the level of activity of the MTHFR enzyme.  
The genetic identification of this polymorphism can be actually performed in a specialized 
laboratory through a blood test. DNA is extracted from blood cells, and the identification of 
the genetic variant is performed with standard techniques as the genome sequencing. The 
result is provided with a turnaround time of 7-10 days. Due to the complexity of the test it is 
not part of the routine analysis. A valid alternative could be a rapid and easy-to-use POC test 
providing genetic pre-screening directly during the Gynecologist’s visit. In this way the 
traditional administration of a high dose of folic acid can be routinely avoided benefiting the 
alternative supplement compound. 
In this thesis a Real-Time strategy for 677C>T polymorphism on MTHFR gene suitable for 
portable testing was developed. In contrast to the currently available analysis, this application 
was designed to be performed in a non-invasive way starting from saliva samples. The 
strategy, as well as for the application described in chapter 4, is suitable to be performed in a 
portable heater fluorimeter. This type of approach would make possible the choice of the 









5.2 Results and discussion 
The optimized single-SNP genotyping LAMP-based strategy, thanks to its highly versatility was 
applied to a third model case addressing a pharmacogenetic issue. In this case, the strategy 
was declined to obtain the detection of the presence of 677C>T polymorphism on MTHFR 
gene. The presence of this SNP is associated with a reduced activity of the MTHFR enzyme 
that is involved in folic acid metabolism. The polymorphism in homozygosis TT generates a 
form of MTHFR enzyme with a reduced activity. In particular, the homozygosis TT genotype 
leads to the production of a form with the 30% of the full enzymatic activity, while the 
heterozygosis CT genotype encodes for an enzyme with a remaining activity of 65%. 
Genotyping in a simple and rapid way this genetic variation has various advantages in clinical 
practice. In particular, it would be useful for choosing the right folic acid supplementation for 
women during pregnancy. In presence of the genetic variation (T) the supplementation with 
the active form of folic acid could be suggested directly by the doctor after a rapid analysis of 
the patient’s genome.  
The purpose of this project was to develop a fluorescent-based strategy suitable for a POC 
approach. Thus, in order to introduce a non-invasive sampling, DNA was extracted from saliva 
samples with the easy-handle protocol described in chapter 4. Loop primers (LPs) for this 
application were designed in order to accomplish the identification of 677C>T SNP. Herein, 
the polymorphic base was detected by the LP-T, while the most frequent allele is identified 
by LP-C. Two reactions were performed in parallel to ensure the correct genotyping of both 
the allele types.  
For homozygous CC or TT samples, only one amplification reaction will be accelerated 
depending on the allele type present in the sample, while the concurrent reaction performed 
with the other loop primer will be delayed. For example, in case of a homozygous CC, the 
accelerated reaction will be the one performed with LP-C, the opposite behavior will occur in 
presence of homozygous TT individuals. In presence of heterozygous CT individuals both 
reaction will be properly enhanced, generating two overlapped curves gave by the same 
amplification efficiency. 
To achieve a fluorescent detection it is important that the amplification curves obtained from 
the analysis of a heterozygous samples were perfectly overlapped and the ones related to the 
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identification of a homozygous sample were sufficiently separated (at least 10 minutes) in 
order to obtain unequivocal results. 
For these purposes, 2 primer sets were tested (LP1-C and LP1-T, LP2-C and LP2-T). 
LP hybridizes to the portion of the target sequence where the SNP is located. The primer set 
1 was proven to operate a sufficient discrimination for homozygous samples. However, the 
curves resulted from the amplification of a heterozygous sample had different amplification 




This result was explained by the fact that LP of set 1 was able to form heterodimers with the 
sequence of others primers involved in the reaction. This unintended bond led to reduce the 
amount of LP in the reaction mix, reducing the availability of the discriminating probes. 
Unfortunately, since in this kind of strategy the primer design is constrained by the SNP site, 
it was not possible to operate a substantial modification on the sequence of the primers. 
Therefore, the subsequent optimization was consisted on raising the reaction temperature of 
2 °C. With a higher temperature the primer annealing is disfavored. This led to a further 
disfavoring of non-specific reactions resulting in a larger time gap between the two 
Figure 1. Real-time fluorescence detection of homozygous CC (a) and heterozygous CT 
samples (b). LAMP reactions were performed with primer set 1 at the reaction temperature 
of 63°C. The same sample was tested twice and for each sample two parallel reactions using 
LP1-C and LP1-T were performed. The accelerated reactions in case of a homozygous sample 




amplification curves in homozygous samples. However, on the other side, at a higher reaction 
temperature, the specific annealing is more random. As a result, the time of onset of all the 
specific reactions, resulting from both homozygous and heterozygous samples, was less 
reproducible and slightly delayed (Figure 2). 
  
 
To increase the result reproducibility, another primer set, set 2, was designed, increasing the 
melting temperature of both primers (LP2-C and LP2-T). Primer set 2 was tested at 65°C and 
the best result was obtained. This optimization led to achieve a compromise between the 
amplification efficiency of 100% matched reactions and the annealing destabilization of the 
single nucleotide mismatched ones (Figure 3). 
All the possible cases were tested, introducing a control sample performed without the pre-
addition on any LP type. As showed in Figure 3a, in case of a wild-type homozygous sample 
CC, the accelerated reaction resulted the one performed with LP2-C, on the contrary with the 
same target the reaction performed with LP2-T was sufficiently delayed. Then, in case of a 
mutant homozygous sample TT, reactions behavior was inverted: the LP-T mediated reaction 
resulted accelerated, while the one mediated by LP-C was delayed (Figure 3b). In both cases, 
the time gap between the two curves distinctly allowed the discrimination. 
Figure 2. Real-time fluorescence detection of homozygous CC (a) and heterozygous CT samples (b). 
LAMP reactions were performed with primer set 1 at the reaction temperature of 65°C. The same 
sample was tested twice and for each sample two parallel reactions using LP1-C and LP1-T were 
performed. The accelerated reactions in case of a homozygous sample were performed with LP1-C, 
while in case of the heterozygous sample, both reactions were accelerated. 
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Finally, in case of a heterozygous sample, both reactions were enhanced with the same speed 
(Figure 3c). In all cases, for all the tested cases, reactions performed without LPs did not 




Figure 3. Real-time fluorescence detection of a homozygous CC (a), a homozygous TT (b) and a 
heterozygous CT (c) samples. LAMP reactions were performed with primer set 2 composed by LP2-C 
(red line) and LP2-T (blue line). Amplification reaction of both heterozygous and homozygous samples 
without the pre-addition of any LP was performed (black line). The time gap between the accelerated 
and the delayed reactions was 20 minutes in case of homozygous CC sample and 40 minutes in case 
of homozygous TT sample. 
 
To confirm these results, 10 people were tested using the optimized SNP genotyping assay. 
The 10 people were the same volunteers tested for the -13910C>T SNP, except for patient 4 
and 8. They were all chosen randomly and their characteristics (e.g. sex and age) were listed 








Patient Sex Age 
1 Female 28 
2 Female 36 
3 Female 33 
4 Male 43 
5 Female 36 
6 Female 29 
7 Female 26 
8 Female 27 
9 Female 35 
10 Male 30 
 
 
Observing the Real-Time results, in all of these cases, the two amplification curves were 
separated enough to distinguish the allele types present in the samples. In case of a 
homozygous sample the LP employed in the reaction that onset faster, indicated the sample 
genotype. In case of heterozygous samples the two curves amplified at the same time, 
indicating the present of both allele types in the sample. Also for this application the 
fluorescent-based detection generated a fast and unequivocal result for each of the tested 
individuals (Figure 4). 
These outcomes were validated comparing the results obtained with the optimized SNP-
sensitive strategy with the results provided by a certified testing laboratory, Lifebrain. 
Currently, Lifebrain offers the analysis of this SNP through a blood test. Since this analysis 
can’t be performed through buccal swab there isn’t the possibility to receive and perform the 
test at home. In fact, a blood draw has to be performed by a healthcare professional or a 
nurse and the sample is analyzed by the specialized laboratory. As well as for the predictive 
tests (chapter 4), the test results are provided with a turnaround time of 7 days. In this case, 
Table 1. In this table are given more details about the 10 people genotyped for the 677C>T SNP. 
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both the collection of the sample and the genetic test have to be performed exclusively in a 
specialized laboratory.  
Remarkably, comparing the results obtained with the optimized SNP assay with the results 
given by Lifebrain test, all the outcomes were validated with 100% of concordance (figure 4 




Figure 4. Real-time fluorescence genotyping of 10 people. LAMP reactions were performed with primer 
set 2 composed by LP2-C (red line) and LP2-T (blue line). Heterozygous samples were detected by the 
correct enhancement of both reactions, while homozygous CC or TT samples were identified by the 
acceleration of the reaction performed with LP corresponding to the allele type. 













Figure 5. Genotyping of 10 individuals for 677C>T genetic variant with a standard test performed by 
Lifebrain and with the optimized strategy based on the enhancement of the perfectly matched 












5.3 Materials and methods  
Optimized protocol for DNA Extraction from saliva samples 
DNA was extracted from saliva samples using the following protocol. 500 μL of saliva were 
collected in a safe lock Eppendorf tube and mixed with 1 mL of Phosphate Saline Buffer 
(PBS). Samples were then centrifuged at 6000 RPM for 10 seconds using Mini 
Microcentrifuge (Labnet International, Edison, New Jersey, USA) and the resulting 
supernatant was discarded. The pellet was suspended in 200 μL of Saliva Pre-treatment 
Buffer  and was mixed at 500 RPM for 10 minutes at 95°C using a ThermoMixer (Eppendorf, 
Milano, Italy). After this step, samples were mixed with using a Vortex Mixer (VWR 
International SRL, Milano, Italy) and then centrifuged for 1 minutes at 6000 RPM using Mini 
Microcentrifuge (Labnet International, Edison, New Jersey, USA). After centrifuge a pellet, 
composed by cells debris and proteins, resulted separated from the surnatant that contains 
the extracted ssDNA. Finally, sample concentration was assessed as described in Chapter 2 
and it was diluted in MilliQ water at the final concentration of 200 copies/μL. 
 
Primer Design for LAMP strategy 
Primer sequences for the Folic Acid pharmacogenetic assay were designed by Dr.ssa Paola 
Cecere of NanoBioInteractions&NanoDiagnostics Group starting from the MTHFR human 
gene.  
 
Fluorescent-based LAMP Reactions for folic acid pharmacogenetic assay 
LAMP reactions were performed in 25 μL of a mixture containing 1.6 μM each of inner 
primers, 0.4 μM each of outer primers, 0.8 μM of loop primers (Integrated DNA 
Technologies, Coralville, IA, USA), 1 M of betaine (VWR International SRL, Milano, Italy), 2.5 
μL of 10X LAMP buffer (200 mM of Tris-HCl, 100 mM of (NH4)2SO4, 20 mM of MgSO4, 500 
mM of KCl, and 1% v/v Tween 20), 2 mM of MgSO4, 0.8 mM each of dNTPs (Promega, 
Madison, WI, USA), 0.112 U/μL of Bst 2.0 WarmStart DNA Polymerase (New England 
BioLabs, Ipswich, MA, USA), and 5 μL of DNA template at the concentration of 200 copies/μL 
of the extracted DNA. DNA-free LAMP reactions were included as negative controls. 
Amplification reactions were performed using forward and backward inner primers (FIP and 
BIP), forward and backward outer primers (F3 and B3), and one loop primer (LP-C or LP-T). 
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For real-time fluorescent LAMP, 1/50,000 diluted SYBR Green (Thermo Fisher 
Scientific,Waltham, MA, USA) was pre-added to the reaction mix. Real-time amplifications 
were performed on an Applied Biosystem real-time instrument (Thermo Fisher 
























A reliable fluorescent-based approach for SNP genotyping was applied to a particular 
pharmacogenetic issue, in particular the detection of the 677C>T polymorphism on MTHFR 
gene. This genetic variation causes the production of an enzyme with a reduced activity, 
which entails a reduced metabolization of folic acid introduced as supplementation. 
The detection resulted accurate and effective in distinguish all the possible genotypes. A non-
invasive and easy handled protocol, using saliva samples, was developed and coupled with 
the fluorescent-based approach enabling to genotyping patients with a turnaround time of a 
2 hours. Results were validated using the gold standard technique performed by a specialized 
laboratory and were confirmed with 100% of concordance. The employment of such assay 
will provide a greater advantage in comparison with the currently available techniques. 
Moreover, this approach would be more affordable and would enable the suggestion of a 
personalized therapy, based on the genetic profile. Overall these findings demonstrated that, 
by adjusting the primer design in accordance with an optimization of reaction conditions, 
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Conclusions and future perspectives 
 
In this thesis work, a single-SNP discriminating strategy based on Loop-Mediated Isothermal 
Amplification (LAMP) was presented. The proposed approach was optimized with the aim to 
move SNP diagnostic technologies from specialized laboratories to decentralized settings.  
SNPs are genetic variations represented by the substitution of a single nucleotide at a specific 
position in the genome with a prevalence greater than 1% in the general population. SNPs 
reflect the natural variability of living organisms, as humans, animals and plants. For this 
reason, SNPs are exploited as markers for genetic testing in several areas. In particular, in 
food quality control, SNPs genotyping provides an unequivocal identification of ingredients 
and varietal discrimination of food products, playing a key role in Identity Preservation along 
all the agri-food value chain. On the other side, in clinical practice, SNPs are associated to 
specific phenotypes that influence the individual responses to certain substances, such as 
nutrients, supplements or drugs. In this way, the genotyping of this kind of SNPs can give 
strategic information on food intolerances predisposition or susceptibility to drug treatments.  
Due to the complexity in terms of costs, laboriousness and required instrumentations, the 
currently SNP genotyping techniques are not adaptable to decentralized settings and on-site 
diagnostics. Therefore, in this thesis work, a single-SNP discriminating strategy suitable for 
Point-of-Care testing was optimized starting from a state-of-art approach, and it was applied 
to three different model cases. In particular, this approach was applied to an industrial 
relevant case addressing a specific requirement for food traceability, the varietal 
discrimination of durum wheat. Additionally, it was applied to two clinical cases, for the 
detection of the genetic predisposition to lactose intolerance and for the detection of a SNP 
which affects folic acid metabolism.  
For the quality control application, the optimized colorimetric strategy was proven to be 
effective in the identification of both substitution and adulteration of mono-varietal grains, 




For clinical fields, the optimized strategy was coupled with a non-invasive sampling, using 
saliva as clinical sample. Additionally, a fast and easy handled protocol for DNA extraction 
was introduced, using a simple and low-cost instrumentation. However, further 
optimization are demanded in order to use directly the sample without the dilution step,  
developing a completely portable strategy requiring only a small benchtop centrifuge and a 
simple heater device for the extraction. 
For both clinically relevant applications, the single-SNP discriminating strategy resulted 
effective in providing a clear SNP genotyping, by detecting both heterozygous and 
homozygous samples. Despite the current available tests that require complex 
instrumentation, the employment of skilled users and necessitate a long turnaround time, 
the proposed assay, was demonstrated to provide SNP genotyping within 2 hours. 
Overall, the strategy resulted versatile and potentially applicable to every case where a 
single SNP is involved. Moreover, the method resulted adaptable to both Real-Time 
fluorescent and colorimetric detections by interpreting the test result observing the 
increase of the fluorescence intensity signals or the color change of the reaction mixtures. 
The acquired expertise coupled with the interest in providing new on-site diagnostics tools 
opens the perspective for future application of the single-SNP discriminating strategy to 














Anti-angiogenic effect of graphene oxide in primary human 
endothelial cells 
 
Alongside the main project, I was involved in another project of the NanoBioInteractions & 
NanoDiagnostics Group regarding the investigation of the possible toxicological effects of 
Graphene Oxide on the angiogenesis process of human endothelial cells. 
The here presented project gave significantly results that are described in the present 
appendix. The results obtained have been published in ACS Appl. Mater. Interfaces 2020, 12, 
20, 22507–22518 doi.org/10.1021/acsami.0c03404 with the title “Antiangiogenic Effect of 
Graphene Oxide in Primary Human Endothelial Cells authored by Giulia Cibecchini, Marina 
Veronesi, Tiziano Catelani, Tiziano Bandiera, Daniela Guarnieri, and Pier Paolo Pompa. 
 
1.1 Introduction 
Endothelium is the inner layer of blood vessels and it is formed by endothelial cells. These 
cells are in direct contact with the bloodstream and act as a physical barrier that regulates 
the passage of endogenous and exogenous substances between the blood and the tissues, 
thus representing one of the primary defense for our organism 1. In addition, endothelial cells 
can promote and sustain the formation process of new blood vessels from preexisting 
vasculature. This phenomenon, called angiogenesis, occurs in physiological conditions to 
maintain the body homeostasis and can be altered in several pathological states such as 
cancer, ischemic and inflammatory diseases 2. Hence, understanding if exogenous agents, 
such as xenobiotics, nanomaterials, etc., may modulate the angiogenesis process is pivotal to 
avoid imbalance in the body homeostasis, and, at the same time, to develop new therapeutic 
strategies in the treatment of the above-mentioned pathologies by exploiting the pro- or anti-
angiogenic effects of these agents. 
Graphene is a single layer of carbon packed in a honeycomb structure 3. Due to its unique 
physical-chemical properties, such as room-temperature electron mobility, mechanical 
properties, optical absorption, impermeability to gases, ability to sustain extremely high 
densities of electric current and the possibility to be chemically functionalized, graphene and 
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its related materials (GRMs) have attracted tremendous attention, opening a wide range of 
potential applications in several fields 4, 3. Among the others, the possible use of GRMs in 
biology and medicine, such as in bio-imaging, cancer theranostics, gene and drug delivery, 
tissue engineering, and biosensing, has been recently reported 5, 6, 4. In particular, graphene 
oxide (GO), the oxidized form of graphene achieved by chemical exfoliation of graphite, is 
considered a promising material for biological applications due to its excellent aqueous 
solubility 4. However, the growing interest on the potential use of GO and the development 
of its large-scale production raise concerns about the nanosafety of this new material, to 
determine any potential risk for humans 7. Therefore, in vitro cytotoxicological investigations 
and systematic evaluations of its biocompatibility are essential to develop GO-based 
biomedical materials before their application in vivo.  
In the last decade, numerous studies have investigated the toxicology of GO on a broad 
spectrum of cell types. However, how GO elicits its biological effects is still not clear. In 
particular, there is a lack of systematic studies on the interaction of GO with biological systems 
to analyze the mechanisms and the molecular pathways involved at the cellular and 
subcellular level. In the assessment of GO safety, it is also fundamental to consider the route 
of exposure that determines the physiological and cellular environment that such materials 
meet when entering the human body, determining their biological effects. Considering the 
application potential of GO as drug or gene carriers, the presence of GO-based materials in 
the bloodstream and the interaction with the blood vessel walls is plausible. Various studies 
reported in the literature have investigated the GO biocompatibility and the possibility to use 
GO to affect angiogenesis. Indeed, many conflicting findings on the effects of the interaction 
of GRMs with the process of formation of new vasculature have been reported to date 8, 9, 10, 
11, 12. To shed light on this scenario, systems biology approaches based on integrated omics 
and bioinformatics analyses could be used as powerful tools to explore the interactions 
between nanomaterials and biosystems 13. Among the others, metabolomics aims at the 
comprehensive characterization of all metabolites and, since metabolites are the products of 
a wide array of biochemical processes, information gained from metabolomics effectively 
complements other cell analyses. 
In this work, we assessed the response of primary human umbilical vein endothelial cells 
(Huvec), chosen as an in vitro model of endothelium 14, 15, 9, after their interaction with GO, by 
taking advantages of an integrated experimental approach based on the combination of 
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cytotoxicity, angiogenesis and metabolomics analyses. In particular, we analyzed in depth 
parameters such as cell morphology, viability, migration, oxidative stress, as well as the 
internalization routes and ability of GO to affect angiogenesis. The results obtained by these 
analyses were correlated to preliminary metabolomics characterization to find the 
relationship between cytotoxicity, angiogenic potential alteration, and cell metabolism 
mediated by GO. 
The results of the following work have been published 16. The project was performed at 
NanoBioInteractions & NanoDiagnostics Group at Italian Institute of Technology in 
collaboration with the research group of Dr. Tiziano Bandiera of D3-Pharma Chemistry, Italian 
Institute of Technology, the Electron Microscopy Facility, Italian Institute of Technology, and 
























1.2 Results and discussion 
Effect of GO exposure on cell viability and cell membrane integrity 
GO flakes used in this work were obtained through oxidation of carbon fibers (GANF Helical-
Ribbon Carbon Nanofibers, GANF). The initial GO suspensions were washed with MilliQ water 
by centrifugation, to remove the presence of acids, until a pH value of ≈5 was observed, as 
previously reported 17. The mean GO flake length, determined by transmission electron 
microscopy (TEM) analysis, was around 400 nm, and the surface charge was negative, around 
−35 mV, at pH 7 17.  
Previous biological experiments carried out with the same GO material on different cell 
systems showed very different outcomes. More precisely, no cytotoxic effect on human 
intestinal epithelial Caco2 cells was observed up to 9 days of chronic exposure mimicking 
dietary ingestion 17. Conversely, primary neurons and astrocytes were significantly affected 
by GO acute exposure 18, 19, 20. In this work, we carefully examined the interactions of GO 
nanoflakes with primary human endothelial Huvec cells. After 24 h incubation with increasing 
concentrations of GO (ranging from 0 to 50 µg/mL), optical microscopy analysis revealed a 
huge amount of GO associated to the cells. In fact, GO appeared as dark areas organized in 
large aggregates or single spots mainly distributed in the cytoplasm and in the perinuclear 
region (Figure 1a). Moreover, at the highest concentrations, some GO aggregates were visible 
outside the cells interacting with the external part of the cell membrane. An even higher 
uptake was observed in HeLa cell line (Figure 1b), treated at the same conditions and used for 
comparison. Such large uptake in both cell types could be due in part to the good dispersion 
of GO nanoflakes at physiological pH as previously reported 17. Because of the significant 
cellular internalization, the effect of GO on cell viability was assessed. To this aim, 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) 
assay was performed after treatment of both Huvec and HeLa cells with different 
concentrations of GO (from 0 to 50 µg/mL) for 24 and 48 h. Despite microscopy observations 
indicated a similar association/internalization of GO in both cell types, the effect on cell 
viability was significantly different. In particular, a dose-dependent cytotoxicity was observed 
in Huvec cells: about 20% and 40% decrease of cell viability was observed after 48 h 
incubation with 25 and 50 µg/mL of GO, respectively (Figure 1c). Conversely, no cell death 
was detected in HeLa cells in the same experimental conditions (Figure 1d) even though the 
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amount of internalized GO was qualitatively comparable/superior to Huvec cells. These 
results further demonstrated the cell-dependent response to the same material, in 
agreement with previous works reporting on the variable biological reactions to GO 
treatment depending on cell type 21, 22, 23, 17. For instance, it was showed that GO was not 
internalized by A549 cell lines and, as a consequence, did not lead to any decrease in cell 
viability 22. Moreover, in Caco2 cells GO was poorly internalized and also in this case it did not 
induce evident cytotoxicity 17. It was further demonstrated that incubating A549 and RAW 
264.7 cells with GO for longer exposure times (4 days), a large amount of the nanomaterial 
was internalized and confined inside vesicular structures, with a resulting time- and dose-
dependent cytotoxicity 23. 
 
 
Figure 1. Optical microscope images of Huvec (a) and HeLa cells (b) after 24 h incubation with 
increasing concentrations of GO, ranging from 0 to 50 μg/mL. Cell viability of Huvec (c) and HeLa (d) 
assessed with MTS assay after 24 and 48 h of incubation with GO. Data are normalized to the values 
of the untreated samples, set to 100% (red line), and represent the average of six different 
experiments performed in triplicate. The error bars represent the standard deviation. One-way 






To elucidate the mechanism underlying the viability decrease in Huvec cells by GO, we first 
looked at the plasma membrane integrity, assessing the extracellular release of lactate 
dehydrogenase (LDH) upon GO exposure. However, as shown in Figure 2, no significant 
variations in released LDH levels were found after 24 and 48 h of incubation with GO at all the 
concentrations tested. Therefore, the reported toxicity of GO was not dependent on the 
breakage of the cell membrane, in spite of its high intracellular accumulation. Consistently, 
other works showed that GO did not induce any damage at the cell membrane of Caco2 cells 
24, 17.  
 
Figure 2. Membrane integrity assay on Huvec cell after GO incubation for 24 and 48 h. Positive 
controls were obtained with lysis solution provided by the kit. Data are normalized on positive control 
samples expressed as 100% and reported as the average ± standard deviation. The graph reports the 
average of three independent experiments. One-way ANOVA was performed to determine statistical 
significance between treatments and negative control (Ctrl-). 
 
Cell uptake and intracellular localization of GO 
Cell uptake and intracellular fate of GO are crucial issues to determine whether GO 
cytotoxicity is related to its interference with intracellular structures and/or pathways. 
Therefore, we analyzed GO intracellular localization by confocal microscopy, by exploiting its 
intrinsic property of efficiently scattering excitation light 25. Numerous spots of GO, 
heterogeneous in size and shape, were visible in the cytosol and around the nucleus of Huvec 
cells (Figure 3), confirming the preliminary observations with the optical microscope. Such 
distribution suggested an endocytosis-mediated uptake of GO nanoflakes, as already 
demonstrated for other cell types 17, 18. In fact, most of nanomaterials enter cells via 
endocytosis 26, 27, are confined in vesicles and, usually, end up into late endosome/lysosome 
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structures 28, 29, 30. To address this issue, Huvec cells were stained with Lysotracker after 24 h 
of incubation with GO at the concentration of 0, 1, and 10 µg/mL. Lysotracker is a probe 
commonly used to study the intracellular trafficking of nanomaterials; it is selectively 
accumulated in lysosomes due to their acidic environment 31, 32. However, as shown in Figure 
4, no apparent colocalization of GO spots with Lysotracker was observed. Moreover, a 
significant decrease of Lysotracker signal was detected with the increase of internalized GO. 
We ascribed the quenching of Lysotracker fluorescence to the co-presence of large GO 
aggregates into lysosomes. In fact, several papers reported on the capability of GO to quench 
the fluorescence emission of other dyes 33, 34, 24, a property that is widely exploited for the 
development of graphene-based nanosensors 35, 36. Therefore, the quenching of Lysotracker 
fluorescence can be considered an indirect evidence of the endo-lysosomal confinement of 




Figure 3. Confocal microscopy images of Huvec cells after 6 h of incubation with GO at the 
concentration of 25 µg/mL. Green spots represent the GO scattering of the laser beam (left panels); 







Figure 4. Confocal microscopy analysis of Huvec cells incubated 24 h with GO at 0 µg/mL (a and d), 1 
µg/mL (b and e) and 10 µg/mL (c and f) and stained with Lysotracker (red) and Hoechst 33342 (blue) 
to highlight lysosomes and nuclei, respectively. Indirect co-localization of GO with lysosomes shown 
as red fluorescence quenching by GO. Top panels: fluorescence images; bottom panels: merge of 
fluorescence and brightfield images. GO appears as dark spots in the brightfield images. 
 
 
To confirm this observation, transmission electron microscopy (TEM) analysis was performed 
(Figure 5), demonstrating the presence of GO nanoflakes inside the cells. GO was found both 
as single lamellar flakes and as big aggregates localized inside vesicular structures, prevalently 
distributed in the perinuclear region. The vesicular structures were likely endo-lysosomal 
compartments, thus indicating that GO material was internalized by endocytosis. 
Furthermore, the morphology of the cells as well as the plasma membrane resulted not to be 
affected by GO uptake, compared to the non-treated control cells (Figure 5 a and d), in 






Figure 5. TEM images of GO flakes internalized in Huvec cells after 24 h of incubation with GO at the 





Effect of GO exposure on angiogenesis 
Huvec cells are able to form capillary-like structures after specific stimulation in vitro 37, 14, 15, 
38. Here, these cells were used to investigate whether their interaction with GO could promote 
or inhibit this process by performing a Matrigel assay. As reported in Figure 6a, the exposure 
of cells to GO for 6 h reduced their capability to form capillary-like structures in a dose-
dependent manner. In particular, we observed a reduction (around 40%) in the number of 
meshes formed by cells treated with the highest GO concentration (50 µg/mL) compared to 
the positive control. In fact, optical microscopy images showed areas with less 
interconnections among the cells forming the capillary network after the treatment with GO 
than in the positive control (Figure 6b).  
Interference of GO with angiogenesis process is a critical issue in the literature. It was 
investigated using various assays and in vitro or in vivo models leading to different and 
conflicting findings. For instance, Mukherjee et al. demonstrated by egg yolk angiogenesis 
assay (chick embryo angiogenesis, CEA) in ECV-304 cells that, depending on the GO 
concentrations and the amount of intracellular ROS formation, this nanomaterial could be 
proangiogenic or anti-angiogenic 8. On the contrary, Pei-Xin Lai et al., using both tube 
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formation assay and chick chorioallantoic membrane (CAM) assay, reported that bovine 
serum albumin-capped GO (BSA-GO) possessed binding affinity towards VEGF-A165, an 
angiogenic factor, inhibiting angiogenesis in Huvec cells by sequestering VEGF-A165 9. 
Moreover, Jeong et al. demonstrated that both GO and PEG-coated GO caused various 
angiogenic patterning defects, such as incomplete vessels, in zebrafish embryos suggesting 
that GO affected the normal growth and branching of vessels by regulating VEGF and Notch 
signaling pathways essential for angiogenesis 10. In agreement with some of these studies, 
our observations showed a negative effect of GO exposure on the angiogenic potential of 
Huvec cells with a dose dependent inhibition of capillary-like structure formation.  
 
 
Figure 6. Capillary tube like-formation assay on Huvec cells after 6 h incubation of GO. Data 
are normalized to positive control samples expressed as 100% and reported as the average ± 
standard deviation. The graph reports the average of six independent experiments (a). 
Representative images of positive control (b) and 50 µg/mL GO treated samples after 6 h of 
incubation (c). One-way ANOVA was performed to determine statistical significance between 




Cell migration ability after GO exposure 
Angiogenesis is a complex process that requires migration of endothelial cells 39. Basically, 
endothelial cells activate migratory pathways in response to growth factors gradients, 
integrins bindings, and mechanical stress induced by blood flow. These stimuli are able to 
drive the remodeling of the actin cytoskeleton into plasma membrane projections and actin 
protrusions, which are involved into the extension at the leading edge, the attachment to 
extracellular matrix and the contraction of the cell body 39, 40. 
We investigated if the intracellular accumulation of GO could interfere with the cell motility 
as a possible explanation of its anti-angiogenic effect. The assessment of the migration ability 
of Huvec cells upon the incubation with GO was performed by a wound healing assay. We 
observed that the interaction with GO affected the ability of cells to heal the wound over time 
and depending on the GO concentration (Figure 7). At the highest concentration (25 µg/mL) 
only ~60% of the wound was repaired compared to the positive control (100%) and cells 
treated with 1 µg/mL of GO (~80%) (Figure 7a). Representative images of Huvec cells acquired 
after 24 h incubation with GO at the concentration of 0, 1 and 25 µg/mL were showed in 
Figure 7(b-d). Similar results were obtained by Zhou et al. who reported that graphene and 
GO both inhibited migration and invasion of cancer cells by suppressing the activity of the 
electron transfer chain in mitochondria, leading to a decrease in ATP production fundamental 
for actin polymerization 41. In contrast, Hussein et al. demonstrated that GO subjected to 
ultra-sonication for two days was biocompatible at low concentrations and promoted cell 
migration 42. Moreover, the use of graphene in wound healing was reported by Lu et al. who 
prepared chitosan–PVA nanofibers containing graphene and by Fan et al. who designed an 
Ag/Graphene polymer hydrogel; both of these composite materials combined wound repair 
with antibacterial intrinsic activity of graphene 43, 44. However, in our experimental conditions, 
GO was abundantly internalized and accumulated inside the cells within endo-lysosomal 
vesicles. Therefore, the close interaction of this nanomaterial with the intracellular machinery 
could elicit different cellular response by affecting specific cell functions and structures. 
Among the others, the rearrangement of cytoskeleton is important for cell migration 45. 
Analyzing the assembly of actin microfilaments, we observed some differences between cells 
treated with GO and non-treated cells (Figure 8). In particular, confocal microscope images of 
Huvec cells treated with GO for 24 h at the concentration of 1 and 10 µg/mL and labelled with 
phalloidin indicated that actin microfilaments appeared less organized in proximity of the GO 
120 
 
intracellular aggregates. On the other hand, actin fibers of untreated cells were orderly 
assembled and oriented inside the cytoplasm. It is known that cell migration and endocytosis 
use the same cellular structures such as cytoskeleton to work. Previously, Frontiñan-Rubio et 
al., observed cytoskeleton alterations in keratinocytes treated with the same GO for 7 days 
46. These observations in association with our results on Huvec migration ability demonstrated 
that GO, internalized and confined inside lysosomes, interfered with the arrangement of cell 
body required for migration process of these cells and consequently with their ability to form 




Figure 7. (a) Wound healing assay on Huvec cells after 0, 6 and 24 h of incubation with GO. Data 
were normalized on the starting time point expressed as 100% (reported as mean ± standard 
deviation of three independent experiments) (b-d). Representative images of Huvec cells labelled with 
Alexa-Fluor 488-phalloidin for F-actin (green) at 24 h time point. Cells were treated with GO at the 
concentration of 0 μg/mL (b), 1 μg/mL (c) and 25 μg/mL (d). Scale bar 100 µm. One-way ANOVA was 
performed to determine statistical significance of treatments (GO 1 and 25 µg/ml) respect to non-































Figure 8. Confocal images of Huvec cells after 24 h of incubation with GO at the concentration of 0 
μg/mL (a, d), 1 μg/mL (b, e) and 10 μg/mL (c, f). Cells were stained with Phalloidin (red) and Hoechst 
33342 (blue) to highlight actin filaments and nuclei, respectively. GO was acquired in brightfield 
mode (dark spots). White arrows highlight GO flakes. 
 
Effect of GO in Reactive Oxygen Species (ROS) production  
The overproduction of ROS is related to cellular stress conditions. To further elucidate the 
effects of GO on Huvec cells, we assessed the generation of ROS after the exposure to 
different concentrations of this material for 24 and 48 h. ROS were detected using 2′,7′-
dichlorodihydrofluorescein diacetate (H2DCFDA) that is a cell permeant molecule, which can 
be oxidized by intracellular ROS forming 2′,7′-dichlorofluorescein (DCF), a green fluorescent 
product, commonly used for the assessment of oxidative stress 23, 22, 47. As reported in Figure 
9a, a significant increase of ROS levels was observed after 24 and 48 h of incubation with GO 
at higher concentrations (50 µg/mL) in comparison with untreated cells. A similar dose 
dependent trend resulted from the viability assay, suggesting that the oxidative stress 
strongly contributes to the toxicity of the GO nanomaterial, in agreement with previous 
studies. In fact, exposure to GO was reported to induce the formation of intracellular ROS in 






Figure 9. (a) ROS levels in Huvec cells untreated or exposed to GO ranging from 1 to 50 µg/mL for 24 
and 48 h. Positive control (Ctrl +) was performed treating cells with 1 mM H2O2 for 15 minutes. Data 
are normalized to untreated cells (Ctrl -) and reported as average ± standard deviation of three 
independent experiments. One-way ANOVA was performed to determine statistical significance 
between treatments and negative control (** p<0.01, * p<0.05). (b) Confocal microscopy images of 
Huvec cells after 24 h incubation with GO. Mitochondria were stained with Rhodamine 123 (red) and 
nuclei with Hoechst 33342 (blue) (top and bottom panels). GO was acquired in brightfield mode (dark 
spots) as reported in the bottom panels that show the merge of fluorescence and brightfield images. 
 
In oxidative stress conditions, most of the ROS are produced by mitochondria. These 
organelles play a vital role in energy production and are involved in programmed cell death 
48, 49, 50, 51. Studying GO related cytotoxicity, Zhou et al. found a correlation between the size 
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of GO flakes and their ability to accept electrons from the electron chain transport in 
mitochondria 41. Therefore, in our study, we looked at mitochondria to verify any possible 
interaction between these intracellular organelles and the internalized GO nanomaterial. TEM 
analysis did not show GO inside or associated to the mitochondria (Figure 5). Moreover, their 
morphology was regular and not affected by the treatment of the cells with GO. These 
observations suggested that there was no direct interaction between the internalized GO and 
mitochondria. However, confocal microscopy analysis of Huvec cells treated with 0, 10 and 
25 μg/mL of GO for 24 h and labelled with Rhodamine 123 dye, which is widely used to mark 
mitochondrial organelles 41, 52, 53, showed differences in their intracellular distribution (Figure 
9 b). We hypothesized that the presence of large GO aggregates confined in endo-lysosomal 
structures could change the local distribution of mitochondria: i) directly, due to physical 
hindrance within the cytoplasm as evidenced in Figure 9b, and ii) indirectly, because of the 
incorrect assembly of microfilaments (Figure 8) that are involved in the intracellular trafficking 
of mitochondria 54. Notably, it has been recently demonstrated that defects in the interaction 
of mitochondria with actin microfilaments compromise mitochondria functionalities and may 
affect cell fate and apoptosis in retinal pigment epithelial cells 55. 
 
Metabolomics analysis by Nuclear Magnetic Resonance (NMR) 
The metabolism of endothelial cells has been recognized as a driving force of angiogenesis 56. 
Changes in endothelial metabolism are able to induce or inhibit different steps of the 
angiogenic process 57. Consequently, external agents capable to reprogram cell metabolism 
may influence their angiogenic potential. To corroborate all the results obtained so far and to 
further clarify how GO interferes with cellular functions, we performed an exploratory 
metabolic analysis of the media conditioned by Huvec cells cultured in presence and in 
absence of 25 µg/mL GO. Nuclear Magnetic Resonance (NMR) is a well-recognized technique 
for the identification and quantification of metabolites in growth media, biofluids, and intact 
tissues 58, 59, 60. The technique is nondestructive, noninvasive, very robust, and shows high 
reproducibility. Moreover, due to its physical characteristic, NMR represents an intrinsically 
quantitative method and allows the simultaneous quantification of different molecules, 
providing a precise picture of the metabolic profile in a precise moment 58. As a preliminary 
study, we focused on the analysis of growth media of GO-treated and untreated cells, which 
were harvested and analyzed after 24 h of incubation. Both unsupervised Principal 
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Component Analysis (PCA) analysis and supervised multivariate analysis (PLS-DA) segregated 
very well the two groups (controls and GO-treated, see Figure 10a and 10b, respectively), 
indicating a different metabolite profile and a consequent alteration of the cell metabolism 
by the graphene-oxide. The quantitative NMR analysis showed a different consumption of 
several metabolites in the samples treated with GO compared to non-treated controls, 
revealing a substantial effect of GO exposure in the metabolic profile of Huvec cells. In 
particular, we found statistically significant differences in consumption levels of niacinamide 
and several amino acids, namely phenylalanine, arginine, isoleucine, proline, tyrosine, leucine 
and glutamine (Figure 10c). Conversely, no differences in consumption of lactate and glucose 
were observed (Figure 10d), likely suggesting no direct interference of GO with glycolysis. 
Niacinamide is a precursor of nicotinamide adenine dinucleotide (NAD+): it is present in the 
extracellular environment, can be transported into cells and used for the synthesis of NAD+ 
61. NAD+ and its reduced form, NADH, play an important role in the maintenance of the cellular 
redox balance. NADH, in fact, participates in several intracellular reactions as electron donor, 
maintaining cellular redox homeostasis 62. In turn, the cellular redox balance is crucial to the 
survival of cells because an increase in oxidative species may trigger apoptotic pathways 62. 
Therefore, an increase in the consumed levels of niacinamide suggests an alteration of 
NAD+/NADH balance and, hence, oxidative stress that we actually observed upon GO 
incubation (Figure 9).  
The observed variation in amino acids consumption further indicates an effect of GO on 
endothelial cell activities. Beside glycolysis and fatty acid oxidation, in recent years, it has 
been shown that amino acid metabolism also plays an important role in regulating and 
maintaining vascular functions 63. These functions include vascular tone, coagulation and 
fibrinolysis, cell growth and differentiation, redox homeostasis, plus immune and 
inflammatory responses. Notably, our results indicated a higher consumption of some 
essential (isoleucine, leucine, and phenylalanine) and non-essential (proline, tyrosine, 
glutamine, and arginine) amino acids. The first ones must be provided by the diet, while the 
second ones can be synthetized de novo by the cells. It has been reported that the increase 
of oxidative stress can reprogram the metabolism and affect de novo amino acid synthesis in 
endothelial cells 63. In general, amino acids are fundamental for the regulation of energy 
metabolism and some of them are linked to the intracellular oxidative stress level in 
endothelial cells. For these reasons, a modification of their consumption levels could be a 
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benchmark of cellular stress 64. In particular, recent studies have demonstrated that 
glutamine catabolism is essential for endothelial proliferation through its role in the 
replenishment of the Krebs cycle 65. Concomitantly, depriving endothelial cells of glutamine 
caused vessel sprouting defects due to impaired proliferation and migration 65 . Furthermore, 
arginine plays a crucial role in regulating the angiogenic process through different products 
of its catabolism. Indeed, arginine is not only involved in protein synthesis, it is also a single 
substrate for endothelial nitric oxide synthase (eNOS) to produce the important 
vasoprotective molecule nitric oxide (NO) 66. Regarding angiogenesis, conflicting data 
suggested that NO can inhibit or stimulate this process depending upon the NO level 67. 
Additionally, proline is a major amino acid for the synthesis of collagen and the production of 
extracellular matrix; therefore, it may play an important role in vascular remodeling 68.  
Although our results were preliminary and other investigations are necessary, these findings 
indicated that GO interfered with biochemical processes of Huvec cells involved in the redox 





Figure 10. Principal Component Analysis (PCA) (a) and Partial Least Squares for Discriminant Analysis 
(PLS- DA) (b) score plots of Huvec cells treated with 25 μg/mL Graphene oxide (T) and without GO (C) 
for 24 h. Boxplots of representative metabolites identified from univariate analysis as significantly 
different between Huvec cells treated with and without GO (T and C, respectively)  (c). Boxplots of 
Glucose, Lactate and Pyruvate metabolites that have shown not significative difference between 






1.3 Materials and methods 
Preparation of GO suspension 
Graphene oxide (GO) was provided by Grupo Antolin (Burgos, Spain). The stock solution was 
prepared by suspending GO nanoflakes in sterile MilliQ water at the final concentration of 0.5 
mg/mL and it was sonicated 5 minutes in an ultrasonic bath (Ultrasonic Cleaner - VWR) before 
each use. GO batches were tested for the presence of endotoxin by Limulus Amebocyte Lysate 
(LAL) assay (Pierce, Thermo Scientific). Negligible levels of endotoxin were found according to 
US Food and Drug Administration (FDA) guidelines. 
 
Cell culture 
Human umbilical vein endothelial cells (Huvec) (Gibco) were cultured in Medium 200 (Gibco) 
supplemented with Low Serum Growth Supplement Kit (LSGS Kit, Gibco) according to the 
manufacturer procedure. The final concentrations of the components in the supplemented 
medium were: 2% v/v fetal bovine serum (FBS), 2% v/v; hydrocortisone, 1 μg/mL; human 
epidermal growth factor, 10 ng/mL; basic fibroblast growth factor, 3 ng/mL; and heparin, 10 
μg/mL. HUVECs were used for experiments between passages 2 and 6. Human cervix 
epithelioid carcinoma cell lines (HeLa) (ATCC) were cultured in Dulbecco’s Modified Eagles 
Medium (DMEM) (Sigma-Aldrich) supplemented with 10% (v/v) FBS (Sigma-Aldrich), 100 
U/mL penicillin and 100 mg/mL streptomycin (Sigma-Aldrich). Cells were maintained in an 
incubator at 37 °C under a humidified atmosphere and 5% CO2.  
 
MTS assay 
Cell viability after exposure to GO was assessed by measurement of the metabolic activity via 
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-cyrboxymethoxy-phenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt) assay (Cell- Titer96 Aqueous One Solution, Promega). The assay was 
performed following the manufacturer’s protocol. Huvec and HeLa cells were seeded in a 96-
well plate at the density of 1 x 104 cells per well and incubated overnight at standard culture 
conditions. The medium was removed, and cells were incubated with different 
concentrations of GO (0, 1, 10, 25, 50 µg/mL), previously dispersed in supplemented Medium 
200 for Huvec cells and complete DMEM for Hela cells. Cells were incubated for 24 and 48 h 
at 37 °C and 5% CO2. Non-treated cells were used as a control. After the incubation, the cell 
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culture medium was removed, replaced by 120 μL of MTS working solution (20 μL MTS 
reagent plus 100 μL of cell culture medium) and incubated with cells for 2 h at 37 °C and 5% 
CO2. The absorbance at 490 nm wavelength of each sample was measured using a plate 
reader (Biotek Synergy HT plate reader). The absorbance value of starting MTS working 
solution diluted in cell culture medium was taken as blank. Cell viability was calculated as 
(Absorbance samples – Absorbance blank). Data were normalized to the control samples 
(non-treated cells) and reported as mean ± standard deviation of four replicates of six 
different experiments. One-way Anova was performed to determine statistical significance. 
 
Membrane integrity assay 
The plasma membrane integrity after exposure to GO was assessed as a function of lactate 
dehydrogenase (LDH) extracellular release by CytoTox-ONE™ Homogeneous Membrane 
Integrity Assay (Promega) following the manufacturer’s protocol. Briefly, Huvec cells were 
seeded in a 96-well plate at the density of 1 x 104 cells per well and were grown overnight at 
standard cell culture conditions. The medium was removed, and cells were incubated with 
different concentrations of GO (0, 1, 10, 25, 50 µg/mL), previously dispersed in cell culture 
medium, for 24 and 48 h at 37 °C. Non-treated cells were used as a control. Assay plate was 
removed from 37 °C incubator and equilibrate to 22 °C approximately 20 minutes before the 
test. Then, 100 μL of CytoTox-ONE™ mix solution were added directly into each well. Positive 
control samples were performed adding 2 μL of lysis buffer solution, provided by the kit, and 
blank samples were prepared mixing 100 μL of CytoTox-ONE™ mix with cell-free culture 
medium. The plate was incubated at 22 °C for 10 minutes. 50 μL of Stop solution were added 
to each well and the absorbance at 560 - 590 nm wavelength was measured using a plate 
reader (Biotek Synergy HT plate reader). The absorbance of blank was subtracted to the 
absorbance of the samples. Data were normalized to negative control samples and reported 
as the average ± standard deviation. The graph reports the average of three independent 
experiments. One-way Anova was performed to determine statistical significance. 
 
Fluorescence cell staining and confocal microscopy analysis 
The intracellular localization of GO was studied by staining lysosomes with LysoTracker dye 
(Life Technologies) at the final concentration 1.54 x 10⁻⁷ M. Briefly, Huvec cells were seeded 
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on a glass bottom dish (WillCo Wells) grown overnight at standard cell culture conditions and 
then incubated with GO at the concentration of 0,1 µg/mL and 25 µg/mL. After 24 h of 
incubation, the cells were washed twice with PBS with Ca²⁺ and Mg²⁺ and incubated with 
LysoTracker in PBS for 15 minutes at 37 °C and 5% CO₂ and Hoechst 33342 (Thermo Fisher 
Scientific) at a concentration of 5 μg/mL for 5 minutes at room temperature. After the 
staining, the cells were washed twice with PBS with Ca²⁺ and Mg²⁺ and Live Cell Imaging 
Medium (Gibco) was added to each dish. Images were acquired in live staining by a confocal 
microscope (Leica SP5 Inverted) with a 63× oil immersion objectives, 405 and 561 nm 
excitation laser wavelengths and a resolution 1024 × 1024 pixels. GO was excited with 488 
nm laser beam and light scattering of the laser was captured localizing the emission window 
at 505-530 nm. To observe cell morphology upon GO incubation, cells were washed twice 
with PBS, fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X100 in PBS and 
stained with Alexa-Fluor 488- phalloidin or Alexa-Fluor 546- phalloidin. Cells were then 
analysed by the confocal microscope as described above. 
 
Transmission Electron Microscopy (TEM) analysis 
To perform TEM analysis, the cells were seeded on a 6 mm glass coverslip, grown overnight 
at standard cell culture conditions and incubated with GO at 0, 1 and 10 µg/mL concentration 
in cell culture medium for 24 h. At the end of incubation, cells were washed with PBS, fixed 
for 2 h in 1.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4), post fixed in 1% 
osmium tetroxide in the same buffer and stained overnight with 1% uranyl acetate aqueous 
solution. Cells were then dehydrated in a graded ethanol series, infiltrated with propylene 
oxide and embedded in epoxy resin (Epon 812, TAAB). Semithin and thin sections of the 
embedded cell monolayer were cut with an ultramicrotome (UC6, Leica) equipped with a 
diamond knife (Diatome). Images were collected with a Jeol JEM 1011 (Jeol, Japan) electron 
microscope, operating at an acceleration voltage of 100 kV, and recorded with a 11 Mp fiber 
optical charge-coupled device (CCD) camera (Gatan Orius SC-1000).  
 
Capillary-like tube formation assay 
Capillary-like tube formation assay was performed by slightly modifying the procedure 
described elsewhere 16. Matrigel Basement Membrane Matrix provided by Corning was 
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thawed by submerging the vial in ice. After that, 50 μL of Matrigel Matrix was added to each 
well of a 96-well plate keeping it on ice all times. Then, the multiwell plate was incubated 30 
minutes at 37 °C and 5% CO₂ to let the gel to form. GO was diluted in Medium 200 with 10% 
FBS at different final concentrations. Cells were harvested, counted and directly suspended 
in the previously prepared GO suspensions at the density of 1 x 104 cells per well. Negative 
controls samples were also prepared suspending cells in serum free medium. The cells were 
then seeded on the top of the preformed gel and incubated 6 h at 37 °C. After the incubation 
time, cells were washed two times with PBS with Ca²⁺ and Mg²⁺ and fixed with 4% 
paraformaldehyde for 20 min at room temperature. Images of the samples were acquired by 
a Microscope Leica 6000 at 5x magnification and analyzed with ImageJ Plugin Angiogenesis 
Analyzer. Data were reported as the average ± standard error of the number of meshes 
formed for each sample. The graph reports the average of six independent experiments. One-
way Anova was performed to determine statistical significance respect to the positive control. 
 
Wound healing assay 
Cells were seeded at 90% of confluence in a 24-well plate. When a cell monolayer for each 
well was formed, a “wound” was created using a 10 μL sterile tip. Then, cells were incubated 
with increasing concentrations of GO, previously dispersed in complete Medium 200, and 
non-treated samples were considered as a control. Four images for each sample were 
acquired by Microscope Leica 6000 after 0, 6 and 24 h from the wound to determine the 
migration rate. The width of the wound was measured using ImageJ (Fiji) and reported as the 
average ± standard deviation. The graph reports the average of three independent 
experiments. One-way Anova was performed to determine statistical significance of the 
treatments respect to the non-treated cells at comparable time-points. 
 
Detection of reactive oxygen species (ROS) by H2DCFDA 
The production of reactive oxygen species (ROS) was determined by 2′,7′-
dichlorodihydrofluorescein diacetate (H2DCFDA) (Invitrogen). Briefly, Huvec cells were 
seeded with 1 × 104 cells in 100 μL of complete cell culture medium per well in a 96-well plate 
and grown overnight under standard cell culture conditions. Then, medium was removed and 
cells were incubated with increasing concentration of GO, previously dispersed in cell culture 
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medium, and incubated for 24 h at 37 °C. Cells were washed two times with Hanks' Balanced 
Salt solution (HBSS) and incubated with H2DCFDA diluted in HBSS at the final concentration 
of 5 µM for 30 minutes at 37 °C. Positive control samples were treated with 1 mM H2O2 for 
15 minutes at 37 °C before the staining with H2DCFDA. A Biotek Synergy HT plate reader was 
used for the DCF fluorescence intensity, setting the excitation filter at 480 nm and the 
emission filter at 520 nm. After the detection of the fluorescence cells were washed twice 
with HBSS and incubated with MTS assay solution for 2 h at 37 °C. The absorbance at 490 nm 
wavelength of each sample was measured using the plate reader as explained before. Data 
from H2DCFDA assay was normalized to the number of cells and the results were reported as 
a percentage. More precisely, the results were reported as the ratio between the 
fluorescence intensity of the DCF and the absorbance of the MTS assay. The results were 
reported as a percentage where the untreated cells represented 100%. The graph reports the 
average of three independent experiments. One-way Anova was performed to determine 
statistical significance. 
 
Metabolomics analysis by Nuclear Magnetic Resonance (NMR) 
Sample preparation:  
Briefly, 2×106 Huvec cells were seeded in a 10 cm plate and were grown overnight at standard 
cell culture conditions. The medium was removed, and cells were incubated with the same 
medium containing 25 g/mL GO (treatment T) or with medium without GO (controls C) for 
24 h at 37 °C: six replicates for each condition T and C. After 24 h, 2 mL of medium for each 
sample were collected, immediately frozen in liquid nitrogen and stored at -80°C until NMR 
analysis. Just before the analysis, the media were thawed on ice and 400 L of each sample 
were diluted with 100 L of a prepared NMR buffer for a final concentration of 150 mM buffer 
Phosphate pH 7.4, 1 mM 2,2′,3,3′-deuterotrimethylsilylproprionic acid (TSP), 0.04% Sodium 
Azide, and 10% D2O (for the lock signal), into 5 mm NMR tube. 
NMR analysis: 
All the NMR experiments were recorded with a Bruker Ultrashield Plus FT-NMR 600 MHz 
ADVANCE III equipped with a Cryoprobe™ QCI 1H/19F–13C/15N–D with a SampleJet™ 
autosampler with temperature control. For each sample, the probe was automatically locked, 
tuned, matched and shimmed. Before measurement, samples were kept for 5 min inside the 
NMR probehead for temperature equilibration at 298 °K. 
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Two NMR spectra were recorded for each sample: a mono-dimensional (1D) 1H NMR 
spectrum with standard pulse sequence water suppression (noesygppr1d, Bruker), with 128 
scans, 64 k data points, a spectral width of 20 ppm, an acquisition time of 2.7 s, a relaxation 
delay of 4 s and a mixing time of 100 ms and a 1D 1H spin−echo Carr−Purcell−Meiboom−Gill 
sequence 17, 18 (cpmgpr1d, Bruker), to suppress large NMR signals arising from high molecular 
weight molecules (i.e. serum proteins). In the cpmg experiments the total echo time was to 
51.2 ms consisting of 128 repetitions with a τ time of 200 μs and a 180° pulse of approximately 
36 μs. Each spectrum was recorded with total of 128 scans 64k data points, a repetition time 
of 4 s and an acquisition time of 2.7 s. The free induction decay was multiplied with an 
exponential window function with 0.3 Hz line broadening prior to Fourier transformation.  
All the 1H NMR chemical shifts are referenced to the TSP signal. 
Metabolomics analysis: 
The spectra were analyzed for the metabolomics studies by Workflow4Metabolomics W4M 
3.0 (http://workflow4metabolomics.org) an online free infrastructure 19 built on the Galaxy 
environment which include from spectra processing, bucketing, and normalization to 
statistical multivariate (i.e. Principal Component Analysis PCA, Partial least squares 
discriminant analysis PLS-DA) and univariate analysis (i.e. One Way analysis with Multiple 
Responses). For the bucketing we used a width of 0.04 ppm, and the samples were normalized 
based on the total intensity: each bucket integration is divided by the integration of the total 
spectrum. The significant NMR buckets, resulted from W4M analysis, were assigned by the 
free software version NMR Suite 8.2 (Chenomx, Edmonton, Canada) in combination with the 
Human Metabolome Database (http://www.hmdb.ca). The identified metabolites were 
quantified using the PULCON method 20 and TOPSPIN 3.2 Bruker software. One-way analysis 
of variance (t-test) was then performed on relative consumption/production of the identified 
metabolites of the controls and treatments by GraphPad Prism 5 software, and values within 










Overall, our findings elucidated the biological effect of GO on primary human endothelial 
cells, suggesting a mechanism of GO-mediated cytotoxicity by taking advantages from an 
integrated approach based on cytotoxicity, angiogenesis, and metabolomics combined 
analysis. Our data demonstrated that GO has a cytotoxic effect on Huvec cells compared to 
HeLa cells, despite a comparable efficiency in the material uptake. Interestingly, our analysis 
showed that the GO acted at different cellular levels affecting various cellular processes, such 
as cell viability, oxidative stress, migration and angiogenesis, directly and indirectly. Actually, 
the steric hindrance of GO intracellular aggregates perturbed the correct assembly of 
cytoskeleton and the distribution of mitochondria, leading to defects in cell migration and an 
increase in oxidative stress. Moreover, preliminary metabolomics analysis allowed a 
comprehensive characterization of the metabolites altered by GO exposure, indicating the 
possible biochemical pathways underlying the angiogenesis processes. These results 
represent a step forward to understand GO-mediated toxicological mechanisms and, at the 
same time, a starting point for future investigations, which are actually ongoing in our group, 
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